<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8"/>
<title>Hemolytic-uremic syndrome - Wikipedia, the free encyclopedia</title>
<script>document.documentElement.className = document.documentElement.className.replace( /(^|\s)client-nojs(\s|$)/, "$1client-js$2" );</script>
<script>(window.RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Hemolytic-uremic_syndrome","wgTitle":"Hemolytic-uremic syndrome","wgCurRevisionId":711338223,"wgRevisionId":711338223,"wgArticleId":542776,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["CS1 maint: Multiple names: authors list","CS1 German-language sources (de)","Articles with contributors link","Nephrology","Syndromes","Acquired hemolytic anemia","Blood disorders"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Hemolytic-uremic_syndrome","wgRelevantArticleId":542776,"wgRequestId":"VxkrFApAMFcAAKghGqUAAABA","wgIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"preview":false,"publish":false},"wgBetaFeaturesFeatures":[],"wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","usePageImages":true,"usePageDescriptions":true},"wgPreferredVariant":"en","wgRelatedArticles":null,"wgRelatedArticlesUseCirrusSearch":true,"wgRelatedArticlesOnlyUseCirrusSearch":false,"wgULSAcceptLanguageList":["en-us","en"],"wgULSCurrentAutonym":"English","wgFlaggedRevsParams":{"tags":{"status":{"levels":1,"quality":2,"pristine":3}}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgNoticeProject":"wikipedia","wgCentralNoticeCategoriesUsingLegacy":["Fundraising","fundraising"],"wgCentralAuthMobileDomain":false,"wgWikibaseItemId":"Q162266","wgVisualEditorToolbarScrollOffset":0});mw.loader.implement("user.options",function($,jQuery){mw.user.options.set({"variant":"en"});});mw.loader.implement("user.tokens",function ( $, jQuery ) {
mw.user.tokens.set({"editToken":"+\\","patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});/*@nomin*/;

});mw.loader.load(["mediawiki.page.startup","mediawiki.legacy.wikibits","ext.centralauth.centralautologin","mmv.head","ext.visualEditor.desktopArticleTarget.init","ext.uls.init","ext.uls.interface","ext.quicksurveys.init","mw.MediaWikiPlayer.loader","mw.PopUpMediaTransform","ext.centralNotice.bannerController","skins.vector.js"]);});</script>
<link rel="stylesheet" href="/w/load.php?debug=false&amp;lang=en&amp;modules=ext.cite.styles%7Cext.gadget.DRN-wizard%2CReferenceTooltips%2Ccharinsert%2Cfeatured-articles-links%2CrefToolbar%2Cswitcher%2Cteahouse%7Cext.math.desktop.styles%7Cext.math.scripts%2Cstyles%7Cext.tmh.thumbnail.styles%7Cext.uls.nojs%7Cext.visualEditor.desktopArticleTarget.noscript%7Cext.wikimediaBadges%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.raggett%2CsectionAnchor%7Cmediawiki.skinning.interface%7Cskins.vector.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector"/>
<meta name="ResourceLoaderDynamicStyles" content=""/>
<link rel="stylesheet" href="/w/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=styles&amp;skin=vector"/>
<script async="" src="/w/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector"></script>
<meta name="generator" content="MediaWiki 1.27.0-wmf.21"/>
<meta name="referrer" content="origin-when-cross-origin"/>
<link rel="alternate" href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Hemolytic-uremic_syndrome"/>
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Hemolytic-uremic_syndrome&amp;action=edit"/>
<link rel="edit" title="Edit this page" href="/w/index.php?title=Hemolytic-uremic_syndrome&amp;action=edit"/>
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png"/>
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico"/>
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)"/>
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd"/>
<link rel="copyright" href="//creativecommons.org/licenses/by-sa/3.0/"/>
<link rel="canonical" href="https://en.wikipedia.org/wiki/Hemolytic-uremic_syndrome"/>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
</head>
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Hemolytic-uremic_syndrome skin-vector action-view">
		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>

							<div id="siteNotice"><!-- CentralNotice --></div>
						<div class="mw-indicators">
</div>
			<h1 id="firstHeading" class="firstHeading" lang="en">Hemolytic-uremic syndrome</h1>
									<div id="bodyContent" class="mw-body-content">
									<div id="siteSub">From Wikipedia, the free encyclopedia</div>
								<div id="contentSub"></div>
												<div id="jump-to-nav" class="mw-jump">
					Jump to:					<a href="#mw-head">navigation</a>, 					<a href="#p-search">search</a>
				</div>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><table class="infobox" style="width:22em">
<tr>
<th colspan="2" style="text-align:center;font-size:125%;font-weight:bold;background-color: lightgrey">Hemolytic-uremic syndrome</th>
</tr>
<tr>
<td colspan="2" style="text-align:center"><a href="/wiki/File:Schizocyte_smear_2009-12-22.JPG" class="image"><img alt="Schizocyte smear 2009-12-22.JPG" src="//upload.wikimedia.org/wikipedia/commons/thumb/8/81/Schizocyte_smear_2009-12-22.JPG/230px-Schizocyte_smear_2009-12-22.JPG" width="230" height="173" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/8/81/Schizocyte_smear_2009-12-22.JPG/345px-Schizocyte_smear_2009-12-22.JPG 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/8/81/Schizocyte_smear_2009-12-22.JPG/460px-Schizocyte_smear_2009-12-22.JPG 2x" data-file-width="1063" data-file-height="798" /></a>
<div><a href="/wiki/Schistocyte" title="Schistocyte">Schistocytes</a> as seen in a person with hemolytic-uremic syndrome</div>
</td>
</tr>
<tr>
<th colspan="2" style="text-align:center">Classification and external resources</th>
</tr>
<tr>
<th scope="row"><a href="/wiki/Specialty_(medicine)" title="Specialty (medicine)">Specialty</a></th>
<td><a href="/wiki/Nephrology" title="Nephrology">Nephrology</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10" title="ICD-10">10</a></th>
<td><a rel="nofollow" class="external text" href="http://apps.who.int/classifications/icd10/browse/2015/en#/D59.3">D59.3</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9-CM</a></th>
<td><a rel="nofollow" class="external text" href="http://www.icd9data.com/getICD9Code.ashx?icd9=283.11">283.11</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/OMIM" title="OMIM" class="mw-redirect">OMIM</a></th>
<td><a rel="nofollow" class="external text" href="http://omim.org/entry/235400">235400</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></th>
<td><a rel="nofollow" class="external text" href="http://www.diseasesdatabase.com/ddb13052.htm">13052</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></th>
<td><a rel="nofollow" class="external text" href="http://www.nlm.nih.gov/medlineplus/ency/article/000510.htm">000510</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></th>
<td><a rel="nofollow" class="external text" href="http://www.emedicine.com/ped/topic960.htm">ped/960</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></th>
<td><a rel="nofollow" class="external text" href="//www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&amp;term=D006463">D006463</a></td>
</tr>
<tr class="noprint">
<td colspan="2" style="text-align:center">
<div style="text-align: right;">[<a href="//www.wikidata.org/wiki/Q162266" class="extiw" title="d:Q162266">edit on Wikidata</a>]</div>
</td>
</tr>
</table>
<p><b>Hemolytic-uremic syndrome</b> (or <b>haemolytic-uraemic syndrome</b>), abbreviated <b>HUS</b>, is a disease characterized by <a href="/wiki/Hemolytic_anemia" title="Hemolytic anemia">hemolytic anemia</a> (anemia caused by destruction of red blood cells), <a href="/wiki/Acute_renal_failure" title="Acute renal failure" class="mw-redirect">acute kidney failure</a> (<a href="/wiki/Uremia" title="Uremia">uremia</a>), and a low <a href="/wiki/Platelet" title="Platelet">platelet</a> count (<a href="/wiki/Thrombocytopenia" title="Thrombocytopenia">thrombocytopenia</a>). It predominantly, but not exclusively, affects children. Most cases are preceded by an episode of infectious, sometimes bloody, <a href="/wiki/Diarrhea" title="Diarrhea">diarrhea</a> acquired as a <a href="/wiki/Foodborne_illness" title="Foodborne illness">foodborne illness</a> or from a contaminated water supply caused by <a href="/wiki/Escherichia_coli_O157:H7" title="Escherichia coli O157:H7"><i>E. coli</i> O157:H7</a>, other non-o157:H7 E. coli serotypes, <i><a href="/wiki/Shigella" title="Shigella">Shigella</a></i>, and <i><a href="/wiki/Campylobacter" title="Campylobacter">Campylobacter</a></i>. A variety of <a href="/wiki/Virus" title="Virus">viruses</a> have also been implicated as a causative agent. It is now the most common cause of acquired <a href="/wiki/Acute_renal_failure" title="Acute renal failure" class="mw-redirect">acute renal failure</a> in childhood. It is a <a href="/wiki/Medical_emergency" title="Medical emergency">medical emergency</a> and carries a 510% mortality rate; of the remainder, the majority recover without major consequences but a small proportion develop <a href="/wiki/Chronic_kidney_disease" title="Chronic kidney disease">chronic kidney disease</a>, meaning at some point they will likely become reliant on <a href="/wiki/Renal_replacement_therapy" title="Renal replacement therapy">renal replacement therapy</a> (dialysis or transplantation). The primary target appears to be the vascular endothelial cell. This may explain the pathogenesis of HUS, in which a characteristic renal lesion is capillary microangiopathy.<sup id="cite_ref-pmid11691946_1-0" class="reference"><a href="#cite_note-pmid11691946-1">[1]</a></sup></p>
<p>HUS was first defined as a <a href="/wiki/Syndrome" title="Syndrome">syndrome</a> in 1955.<sup id="cite_ref-pmid1816053_2-0" class="reference"><a href="#cite_note-pmid1816053-2">[2]</a></sup><sup id="cite_ref-pmid13274004_3-0" class="reference"><a href="#cite_note-pmid13274004-3">[3]</a></sup> The more common form of the disease, Shiga-like toxin-producing <i>E. coli</i> HUS (<a href="/wiki/STEC-HUS" title="STEC-HUS" class="mw-redirect">STEC-HUS</a>), is triggered by the infectious agent <i>E. coli</i> O157:H7, and several other non-O157:H7 E. coli serotypes. Certain Shiga toxin secreting strains of <i><a href="/wiki/Shigella_dysenteriae" title="Shigella dysenteriae">Shigella dysenteriae</a></i> can also cause HUS.<sup id="cite_ref-4" class="reference"><a href="#cite_note-4">[4]</a></sup> Approximately 5% of cases are classified as pneumococcal HUS, which results from infection by <i>Streptococcus pneumoniae</i>, the agent that causes traditional lobar pneumonia.<sup id="cite_ref-Shimizu2012_5-0" class="reference"><a href="#cite_note-Shimizu2012-5">[5]</a></sup> There is also a rare, chronic, and severe form known as <a href="/wiki/Atypical_hemolytic_uremic_syndrome" title="Atypical hemolytic uremic syndrome">atypical hemolytic uremic syndrome</a> (aHUS), which is caused by genetic defects resulting in chronic, uncontrolled <a href="/wiki/Complement_system" title="Complement system">complement</a> activation.<sup id="cite_ref-Noris2009_6-0" class="reference"><a href="#cite_note-Noris2009-6">[6]</a></sup> Both STEC-HUS and aHUS cause <a href="/wiki/Endothelial" title="Endothelial" class="mw-redirect">endothelial</a> damage, <a href="/wiki/Leukocyte" title="Leukocyte" class="mw-redirect">leukocyte</a> activation, <a href="/wiki/Platelet" title="Platelet">platelet</a> activation, and widespread <a href="/wiki/Inflammation" title="Inflammation">inflammation</a> and multiple thromboses in the small blood vessels, a condition known as systemic <a href="/wiki/Thrombotic_microangiopathy" title="Thrombotic microangiopathy">thrombotic microangiopathy</a> (TMA), which leads to thrombotic events as well as organ damage/failure and death.<sup id="cite_ref-Benz2010_7-0" class="reference"><a href="#cite_note-Benz2010-7">[7]</a></sup><sup id="cite_ref-Zipfel2010_8-0" class="reference"><a href="#cite_note-Zipfel2010-8">[8]</a></sup></p>
<p></p>
<div id="toc" class="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Signs_and_symptoms"><span class="tocnumber">1</span> <span class="toctext">Signs and symptoms</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Atypical_HUS"><span class="tocnumber">2</span> <span class="toctext">Atypical HUS</span></a></li>
<li class="toclevel-1 tocsection-3"><a href="#Pathogenesis"><span class="tocnumber">3</span> <span class="toctext">Pathogenesis</span></a></li>
<li class="toclevel-1 tocsection-4"><a href="#Diagnosis"><span class="tocnumber">4</span> <span class="toctext">Diagnosis</span></a></li>
<li class="toclevel-1 tocsection-5"><a href="#Treatment"><span class="tocnumber">5</span> <span class="toctext">Treatment</span></a></li>
<li class="toclevel-1 tocsection-6"><a href="#Prognosis"><span class="tocnumber">6</span> <span class="toctext">Prognosis</span></a></li>
<li class="toclevel-1 tocsection-7"><a href="#Epidemiology"><span class="tocnumber">7</span> <span class="toctext">Epidemiology</span></a></li>
<li class="toclevel-1 tocsection-8"><a href="#See_also"><span class="tocnumber">8</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1 tocsection-9"><a href="#References"><span class="tocnumber">9</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-10"><a href="#External_links"><span class="tocnumber">10</span> <span class="toctext">External links</span></a></li>
</ul>
</div>
<p></p>
<h2><span class="mw-headline" id="Signs_and_symptoms">Signs and symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hemolytic-uremic_syndrome&amp;action=edit&amp;section=1" title="Edit section: Signs and symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>STEC-HUS occurs after ingestion of a strain of bacteria expressing shiga toxin(s), usually types of <i><a href="/wiki/E._coli" title="E. coli" class="mw-redirect">E. coli</a></i>, that expresses <a href="/wiki/Verotoxin" title="Verotoxin" class="mw-redirect">verotoxin</a> (also called <a href="/wiki/Shiga-like_toxin" title="Shiga-like toxin">Shiga-like toxin</a>). E. coli can produce stx1 and/or stx2 <a href="/wiki/Shiga_toxins" title="Shiga toxins" class="mw-redirect">shiga toxins</a>, the latter being more dangerous and a combination of both toxins in certain ratios is usually associated with HUS. These shiga toxins bind GB3 receptors, <a href="/wiki/Globotriaosylceramide" title="Globotriaosylceramide">globotriaosylceramide</a>, which are present in renal tissue more than any other tissue and are also found in central nervous system neurons and other tissue. Children have more GB3 receptors than adults which may be why children are more susceptible to HUS. Cattle, swine, deer, and other mammals do not have GB3 receptors, but can be asymptomatic carriers of <a href="/wiki/Shiga_toxin" title="Shiga toxin">shiga toxin</a> producing bacteria. Some humans can also asymptomatic carriers. Once the bacteria colonizes, diarrhea followed by bloody <a href="/wiki/Diarrhea" title="Diarrhea">diarrhea</a>, hemorrhagic colitis, typically follows. HUS develops about 510 days after onset of diarrhea, with decreased urine output (<a href="/wiki/Oliguria" title="Oliguria">oliguria</a>), blood in the urine (<a href="/wiki/Hematuria" title="Hematuria">hematuria</a>), <a href="/wiki/Kidney_failure" title="Kidney failure" class="mw-redirect">kidney failure</a>, <a href="/wiki/Thrombocytopenia" title="Thrombocytopenia">thrombocytopenia</a> (low levels of <a href="/wiki/Platelets" title="Platelets" class="mw-redirect">platelets</a>) and destruction of red blood cells (<a href="/wiki/Microangiopathic_hemolytic_anemia" title="Microangiopathic hemolytic anemia">microangiopathic hemolytic anemia</a>). <a href="/wiki/Hypertension" title="Hypertension">Hypertension</a> is common. In some cases, there are prominent neurologic changes.<sup id="cite_ref-Boyer2011_9-0" class="reference"><a href="#cite_note-Boyer2011-9">[9]</a></sup><sup id="cite_ref-Kumar2002_10-0" class="reference"><a href="#cite_note-Kumar2002-10">[10]</a></sup><sup id="cite_ref-Nathanson2010_11-0" class="reference"><a href="#cite_note-Nathanson2010-11">[11]</a></sup></p>
<p>Patients with HUS commonly exhibit the signs and symptoms of <a href="/wiki/Thrombotic_microangiopathy" title="Thrombotic microangiopathy">thrombotic microangiopathy</a> (TMA), which can include abdominal pain,<sup id="cite_ref-Ohanian2011_12-0" class="reference"><a href="#cite_note-Ohanian2011-12">[12]</a></sup> low platelet count,<sup id="cite_ref-Loirat2008_13-0" class="reference"><a href="#cite_note-Loirat2008-13">[13]</a></sup> elevated <a href="/wiki/Lactate_dehydrogenase" title="Lactate dehydrogenase">lactate dehydrogenase</a> LDH, a chemical released from damaged cells, and which is therefore a marker of cellular damage)<sup id="cite_ref-Caprioli2006_14-0" class="reference"><a href="#cite_note-Caprioli2006-14">[14]</a></sup> decreased haptoglobin (indicative of the breakdown of red blood cells)<sup id="cite_ref-Caprioli2006_14-1" class="reference"><a href="#cite_note-Caprioli2006-14">[14]</a></sup> anemia (low red blood cell count)/schistocytes (damaged red blood cells),<sup id="cite_ref-Loirat2008_13-1" class="reference"><a href="#cite_note-Loirat2008-13">[13]</a></sup><sup id="cite_ref-Caprioli2006_14-2" class="reference"><a href="#cite_note-Caprioli2006-14">[14]</a></sup> elevated creatinine (a protein waste product generated by muscle metabolism and eliminated renally,<sup id="cite_ref-Ariceta2009_15-0" class="reference"><a href="#cite_note-Ariceta2009-15">[15]</a></sup> proteinuria (indicative of kidney injury),<sup id="cite_ref-Sellier2007_16-0" class="reference"><a href="#cite_note-Sellier2007-16">[16]</a></sup> confusion,<sup id="cite_ref-Ohanian2011_12-1" class="reference"><a href="#cite_note-Ohanian2011-12">[12]</a></sup> fatigue,<sup id="cite_ref-Noris2010_17-0" class="reference"><a href="#cite_note-Noris2010-17">[17]</a></sup> <a href="/wiki/Edema" title="Edema">edema</a> (swelling),<sup id="cite_ref-Stahl2008_18-0" class="reference"><a href="#cite_note-Stahl2008-18">[18]</a></sup> nausea/vomiting,<sup id="cite_ref-Dragon2010_19-0" class="reference"><a href="#cite_note-Dragon2010-19">[19]</a></sup> and diarrhea.<sup id="cite_ref-Zuber2011_20-0" class="reference"><a href="#cite_note-Zuber2011-20">[20]</a></sup> Additionally, patients with aHUS typically present with an abrupt onset of systemic signs and symptoms such as acute kidney failure,<sup id="cite_ref-Loirat2008_13-2" class="reference"><a href="#cite_note-Loirat2008-13">[13]</a></sup> <a href="/wiki/Hypertension" title="Hypertension">hypertension</a> (high blood pressure),<sup id="cite_ref-Noris2010_17-1" class="reference"><a href="#cite_note-Noris2010-17">[17]</a></sup> myocardial infarction (heart attack),<sup id="cite_ref-Sallee2010_21-0" class="reference"><a href="#cite_note-Sallee2010-21">[21]</a></sup> stroke,<sup id="cite_ref-Ohanian2011_12-2" class="reference"><a href="#cite_note-Ohanian2011-12">[12]</a></sup> lung complications,<sup id="cite_ref-Sallee2010_21-1" class="reference"><a href="#cite_note-Sallee2010-21">[21]</a></sup> <a href="/wiki/Pancreatitis" title="Pancreatitis">pancreatitis</a> (inflammation of the pancreas),<sup id="cite_ref-Dragon2010_19-1" class="reference"><a href="#cite_note-Dragon2010-19">[19]</a></sup> liver necrosis (death of liver cells or tissue),<sup id="cite_ref-Loirat2008_13-3" class="reference"><a href="#cite_note-Loirat2008-13">[13]</a></sup><sup id="cite_ref-Noris2010_17-2" class="reference"><a href="#cite_note-Noris2010-17">[17]</a></sup> <a href="/wiki/Encephalopathy" title="Encephalopathy">encephalopathy</a> (brain dysfunction),<sup id="cite_ref-Noris2010_17-3" class="reference"><a href="#cite_note-Noris2010-17">[17]</a></sup> seizure,<sup id="cite_ref-Neuhaus1997_22-0" class="reference"><a href="#cite_note-Neuhaus1997-22">[22]</a></sup> and coma.<sup id="cite_ref-Noris2005_23-0" class="reference"><a href="#cite_note-Noris2005-23">[23]</a></sup> Failure of neurologic, cardiac, renal, and gastrointestinal (GI) organs, as well as death, can occur unpredictably at any time, either very quickly or following prolonged symptomatic or asymptomatic disease progression.<sup id="cite_ref-Noris2009_6-1" class="reference"><a href="#cite_note-Noris2009-6">[6]</a></sup><sup id="cite_ref-Benz2010_7-1" class="reference"><a href="#cite_note-Benz2010-7">[7]</a></sup><sup id="cite_ref-Loirat2008_13-4" class="reference"><a href="#cite_note-Loirat2008-13">[13]</a></sup><sup id="cite_ref-Sellier2007_16-1" class="reference"><a href="#cite_note-Sellier2007-16">[16]</a></sup><sup id="cite_ref-Mache2009_24-0" class="reference"><a href="#cite_note-Mache2009-24">[24]</a></sup></p>
<h2><span class="mw-headline" id="Atypical_HUS">Atypical HUS</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hemolytic-uremic_syndrome&amp;action=edit&amp;section=2" title="Edit section: Atypical HUS">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div role="note" class="hatnote relarticle mainarticle">Main article: <a href="/wiki/Atypical_hemolytic_uremic_syndrome" title="Atypical hemolytic uremic syndrome">Atypical hemolytic uremic syndrome</a></div>
<p>Atypical HUS (aHUS) represents 5-10% of HUS cases<sup id="cite_ref-Noris2009_6-2" class="reference"><a href="#cite_note-Noris2009-6">[6]</a></sup> and is largely due to one or several genetic mutations that cause chronic, uncontrolled, and excessive activation of complement.<sup id="cite_ref-Noris2009_6-3" class="reference"><a href="#cite_note-Noris2009-6">[6]</a></sup> This results in platelet activation <a href="/wiki/Endothelial_cell" title="Endothelial cell" class="mw-redirect">endothelial cell</a> damage, and white blood cell activation, leading to systemic TMA, which manifests as decreased platelet count, <a href="/wiki/Hemolysis" title="Hemolysis">hemolysis</a> (breakdown of red blood cells), damage to multiple organs, and ultimately death.<sup id="cite_ref-Benz2010_7-2" class="reference"><a href="#cite_note-Benz2010-7">[7]</a></sup><sup id="cite_ref-Sellier2007_16-2" class="reference"><a href="#cite_note-Sellier2007-16">[16]</a></sup><sup id="cite_ref-Tsai2010_25-0" class="reference"><a href="#cite_note-Tsai2010-25">[25]</a></sup> Early signs of systemic complement-mediated TMA include <a href="/wiki/Thrombocytopenia" title="Thrombocytopenia">thrombocytopenia</a> (platelet count below 150,000 or a decrease from baseline of at least 25%)<sup id="cite_ref-Caprioli2006_14-3" class="reference"><a href="#cite_note-Caprioli2006-14">[14]</a></sup> and evidence of microangiopathic hemolysis, which is characterized by elevated LDH levels, decreased haptoglobin, decreased hemoglobin (the oxygen-containing component of blood), and/or the presence of schistocytes.<sup id="cite_ref-Benz2010_7-3" class="reference"><a href="#cite_note-Benz2010-7">[7]</a></sup><sup id="cite_ref-Zipfel2010_8-1" class="reference"><a href="#cite_note-Zipfel2010-8">[8]</a></sup><sup id="cite_ref-Caprioli2006_14-4" class="reference"><a href="#cite_note-Caprioli2006-14">[14]</a></sup> Despite the use of supportive care, an estimated 33-40% of patients will die or have <a href="/wiki/End-stage_renal_disease" title="End-stage renal disease" class="mw-redirect">end-stage renal disease</a>(ESRD) with the first clinical manifestation of aHUS,<sup id="cite_ref-Zuber2011_20-1" class="reference"><a href="#cite_note-Zuber2011-20">[20]</a></sup><sup id="cite_ref-Sallee2010_21-2" class="reference"><a href="#cite_note-Sallee2010-21">[21]</a></sup> and 65% of patients will die, require dialysis, or have permanent renal damage within the first year after diagnosis despite plasma exchange or plasma infusion (PE/PI) therapy.<sup id="cite_ref-Zuber2011_20-2" class="reference"><a href="#cite_note-Zuber2011-20">[20]</a></sup> Patients who survive the presenting signs and symptoms of aHUS endure a chronic thrombotic and inflammatory state, which puts them at lifelong elevated risk of sudden blood clotting, kidney failure, other severe complications and premature death.<sup id="cite_ref-Zipfel2010_8-2" class="reference"><a href="#cite_note-Zipfel2010-8">[8]</a></sup><sup id="cite_ref-Stahl2008_18-1" class="reference"><a href="#cite_note-Stahl2008-18">[18]</a></sup></p>
<p>Historically, treatment options for aHUS were limited to <a href="/wiki/Plasma_exchange" title="Plasma exchange" class="mw-redirect">plasma exchange</a> or plasma infusion (PE/PI) therapy, which carries significant safety risks<sup id="cite_ref-George2010_26-0" class="reference"><a href="#cite_note-George2010-26">[26]</a></sup><sup id="cite_ref-Michon2007_27-0" class="reference"><a href="#cite_note-Michon2007-27">[27]</a></sup> and has not been proven effective in any controlled clinical trials. Patients with aHUS and ESRD have also had to undergo lifelong dialysis, which has a 5-year survival rate of 34-38%.<sup id="cite_ref-Collins2010_28-0" class="reference"><a href="#cite_note-Collins2010-28">[28]</a></sup><sup id="cite_ref-European_29-0" class="reference"><a href="#cite_note-European-29">[29]</a></sup> In recent years the <a href="/wiki/Monoclonal_antibody" title="Monoclonal antibody">monoclonal antibody</a> <a href="/wiki/Eculizumab" title="Eculizumab">eculizumab</a> (<a href="/wiki/International_Nonproprietary_Name" title="International Nonproprietary Name" class="mw-redirect">INN</a> and <a href="/wiki/USAN" title="USAN" class="mw-redirect">USAN</a>, trade name Soliris), a first-in-class terminal <a href="/wiki/Complement_system" title="Complement system">complement</a> inhibitor, has been shown in clinical studies to block terminal complement activity in children and adults with aHUS, and to eliminate the need for PE/PI and new dialysis. In these studies eculizumab was associated with reduced TMA activity, as shown by improvement in platelet counts and kidney function, as well as hematologic normalization, complete TMA response, and TMA event-free status in a majority of patients.<sup id="cite_ref-Soliris_30-0" class="reference"><a href="#cite_note-Soliris-30">[30]</a></sup></p>
<h2><span class="mw-headline" id="Pathogenesis">Pathogenesis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hemolytic-uremic_syndrome&amp;action=edit&amp;section=3" title="Edit section: Pathogenesis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>HUS is one of the <a href="/wiki/Thrombotic_microangiopathies" title="Thrombotic microangiopathies" class="mw-redirect">thrombotic microangiopathies</a>, a category of disorders that includes STEC-HUS, aHUS, and <a href="/wiki/Thrombotic_thrombocytopenic_purpura" title="Thrombotic thrombocytopenic purpura">thrombotic thrombocytopenic purpura</a> (TTP). STEC-HUS is usually preceded by a <a href="/wiki/Prodrome" title="Prodrome">prodrome</a> of diarrhea, which is often bloody, and is caused by Shiga-like toxin-producing bacteria such as enterohemorrhagic <i>Escherichia coli</i> (EHEC), of which <i>E. coli</i> O157:H7 is the most common serotype.<sup id="cite_ref-Palermo2009_31-0" class="reference"><a href="#cite_note-Palermo2009-31">[31]</a></sup> Other serotypes also cause disease and can emerge as new causes of STEC-HUS, as occurred with <i>E. coli</i> O104:H4, which triggered a 2011 epidemic of STEC-HUS in <a href="/wiki/Germany" title="Germany">Germany</a>.<sup id="cite_ref-Robert_32-0" class="reference"><a href="#cite_note-Robert-32">[32]</a></sup></p>
<p>The typical pathophysiology of HUS involves the binding of Shiga-toxin to the globotriaosylceramide (Gb3; also called ceramide trihexoside which accumulates in <a href="/wiki/Fabry_disease" title="Fabry disease">Fabry disease</a>) receptor on the surface of the glomerular endothelium.<sup id="cite_ref-Psotka2009_33-0" class="reference"><a href="#cite_note-Psotka2009-33">[33]</a></sup> This action includes a cascade of signaling events leading to <a href="/wiki/Apoptosis" title="Apoptosis">apoptosis</a> and binding of <a href="/wiki/Leukocytes" title="Leukocytes" class="mw-redirect">leukocytes</a> to endothelial cells. The Shiga-toxin-activated endothelial cells then become <a href="/wiki/Thrombogenic" title="Thrombogenic" class="mw-redirect">thrombogenic</a> (clot-producing) by mechanism that is not fully understood,<sup id="cite_ref-Zoja2010_34-0" class="reference"><a href="#cite_note-Zoja2010-34">[34]</a></sup> though they have been shown to induce the release of <a href="/wiki/Cytokines" title="Cytokines" class="mw-redirect">cytokines</a> and <a href="/wiki/Chemokines" title="Chemokines" class="mw-redirect">chemokines</a> that are implicated in platelet activation.<sup id="cite_ref-Guessous2005_35-0" class="reference"><a href="#cite_note-Guessous2005-35">[35]</a></sup> Additionally, the binding action of Shiga-toxin inactivates a <a href="/wiki/Metalloproteinase" title="Metalloproteinase">metalloproteinase</a> called <a href="/wiki/ADAMTS13" title="ADAMTS13">ADAMTS13</a>, the deficiency of which causes the closely related TTP. Once ADAMTS13 is disabled, multimers of <a href="/wiki/Von_Willebrand_Factor" title="Von Willebrand Factor" class="mw-redirect">von Willebrand Factor</a> (vWF) form and initiate platelet activation, causing microthrombus formation. The activation of platelets resulting from inhibition of ADAMTS13 is due to the hyperactivity of large multimers of uncleaved vWF. The <a href="/wiki/Arterioles" title="Arterioles" class="mw-redirect">arterioles</a> and <a href="/wiki/Capillaries" title="Capillaries" class="mw-redirect">capillaries</a> of the body become obstructed by the resulting complexes of activated <a href="/wiki/Platelets" title="Platelets" class="mw-redirect">platelets</a>, which have adhered to the endothelium via large multimeric vWF. Through a mechanism known as <a href="/w/index.php?title=Microangiopathic_hemolysis&amp;action=edit&amp;redlink=1" class="new" title="Microangiopathic hemolysis (page does not exist)">microangiopathic hemolysis</a>, the growing thrombi lodged in smaller vessels destroy <a href="/wiki/Red_blood_cells" title="Red blood cells" class="mw-redirect">red blood cells</a> (RBCs) as they squeeze through the narrowed blood vessels, forming <a href="/wiki/Schistocytes" title="Schistocytes" class="mw-redirect">schistocytes</a>, or fragments of sheared RBCs.<sup id="cite_ref-Tsai2010_25-1" class="reference"><a href="#cite_note-Tsai2010-25">[25]</a></sup> The presence of schistocytes is a key finding that helps to diagnose HUS. Typically, this hemolysis results in a hemoglobin level of less than 80&#160;g/L.</p>
<p>Shiga-toxin directly activates the alternative complement pathway and also interferes with complement regulation by binding to complement factor H, an inhibitor of the complement cascade. Shiga-toxin causes complement-mediated platelet, leukocyte, and endothelial cell activation, resulting in systemic hemolysis, inflammation and thrombosis.<sup id="cite_ref-Orth2010_36-0" class="reference"><a href="#cite_note-Orth2010-36">[36]</a></sup><sup id="cite_ref-Stahl2011_37-0" class="reference"><a href="#cite_note-Stahl2011-37">[37]</a></sup><sup id="cite_ref-Thurman2009_38-0" class="reference"><a href="#cite_note-Thurman2009-38">[38]</a></sup> Severe clinical complications of TMA have been reported in patients from 2 weeks to more than 44 days after presentation with STEC-HUS, with improvements in clinical condition extending beyond this time frame, suggesting that complement activation persists beyond the acute clinical presentation and for at least 4 months.<sup id="cite_ref-Mache2010_39-0" class="reference"><a href="#cite_note-Mache2010-39">[39]</a></sup></p>
<p>The consumption of platelets as they adhere to the thrombi lodged in the small vessels typically leads to mild or moderate thrombocytopenia with a platelet count of less than 60,000 per microliter.<sup id="cite_ref-Tan2011_40-0" class="reference"><a href="#cite_note-Tan2011-40">[40]</a></sup> As in the related condition TTP, reduced blood flow through the narrowed blood vessels of the <a href="/wiki/Microvasculature" title="Microvasculature" class="mw-redirect">microvasculature</a> leads to reduced blood flow to vital organs, and <a href="/wiki/Ischemia" title="Ischemia">ischemia</a> may develop.<sup id="cite_ref-Boyer2011_9-1" class="reference"><a href="#cite_note-Boyer2011-9">[9]</a></sup> The <a href="/wiki/Kidneys" title="Kidneys" class="mw-redirect">kidneys</a> and the <a href="/wiki/Central_nervous_system" title="Central nervous system">central nervous system</a> (brain and spinal cord) are the parts of the body most critically dependent on high blood flow, and are thus the most likely organs to be affected. However, in comparison to TTP, the kidneys tend to be more severely affected in HUS, and the central nervous system is less commonly affected.<sup id="cite_ref-Kanso2008_41-0" class="reference"><a href="#cite_note-Kanso2008-41">[41]</a></sup></p>
<p>In contrast with typical <a href="/wiki/Disseminated_intravascular_coagulation" title="Disseminated intravascular coagulation">disseminated intravascular coagulation</a> seen with other causes of <a href="/wiki/Septicemia" title="Septicemia" class="mw-redirect">septicemia</a> and occasionally with advanced cancer, <a href="/wiki/Coagulation_factors" title="Coagulation factors" class="mw-redirect">coagulation factors</a> are not consumed in HUS (or TTP) and the <a href="/wiki/Coagulation_screen" title="Coagulation screen">coagulation screen</a>, <a href="/wiki/Fibrinogen" title="Fibrinogen">fibrinogen</a> level, and assays for <a href="/wiki/Fibrin_degradation_products" title="Fibrin degradation products" class="mw-redirect">fibrin degradation products</a> such as "D-Dimers", are generally normal despite the low platelet count (thrombocytopenia).<sup id="cite_ref-Kanso2008_41-1" class="reference"><a href="#cite_note-Kanso2008-41">[41]</a></sup></p>
<p>HUS occurs after 3-7% of all sporadic <i>E. coli</i> O157:H7 infections and up to approximately 20% or more of epidemic infections.<sup id="cite_ref-Mead1998_42-0" class="reference"><a href="#cite_note-Mead1998-42">[42]</a></sup> Children and adolescents are commonly affected.<sup id="cite_ref-Ruggenenti2001_43-0" class="reference"><a href="#cite_note-Ruggenenti2001-43">[43]</a></sup> Grossly, the kidneys may show patchy or diffuse <a href="/wiki/Renal_cortical_necrosis" title="Renal cortical necrosis">renal cortical necrosis</a>. <a href="/wiki/Histologically" title="Histologically" class="mw-redirect">Histologically</a>, the <a href="/wiki/Glomeruli" title="Glomeruli" class="mw-redirect">glomeruli</a> show thickened and sometimes split capillary walls due largely to endothelial swelling. Large deposits of fibrin-related materials in the capillary lumens, subendothelially, and in the <a href="/wiki/Mesangium" title="Mesangium">mesangium</a> are also found along with mesangiolysis. Interlobular and afferent arterioles show fibrinoid necrosis and intimal <a href="/wiki/Hyperplasia" title="Hyperplasia">hyperplasia</a> and are often occluded by thrombi.<sup id="cite_ref-Kumar2002_10-1" class="reference"><a href="#cite_note-Kumar2002-10">[10]</a></sup></p>
<p>STEC-HUS most often affects infants and young children, but also occurs in adults. The most common form of transmission is ingestion of undercooked meat, unpasteurized fruits and juices, contaminated produce, contact with unchlorinated water, and person-to-person transmission in daycare or long-term care facilities.<sup id="cite_ref-Noris2005_23-1" class="reference"><a href="#cite_note-Noris2005-23">[23]</a></sup></p>
<p>Unlike typical HUS, aHUS does not follow STEC infection and is thought to result from one or several genetic mutations that cause chronic, uncontrolled, and excessive activation of complement.<sup id="cite_ref-Noris2009_6-4" class="reference"><a href="#cite_note-Noris2009-6">[6]</a></sup> This leads to <a href="/wiki/Platelet" title="Platelet">platelet</a> activation, <a href="/wiki/Endothelial_cell" title="Endothelial cell" class="mw-redirect">endothelial cell</a> damage, and white blood cell activation, leading to systemic TMA, which manifests as decreased platelet count, <a href="/wiki/Hemolysis" title="Hemolysis">hemolysis</a>, damage to multiple organs, and ultimately, death.<sup id="cite_ref-Benz2010_7-4" class="reference"><a href="#cite_note-Benz2010-7">[7]</a></sup><sup id="cite_ref-Sellier2007_16-3" class="reference"><a href="#cite_note-Sellier2007-16">[16]</a></sup><sup id="cite_ref-Tsai2010_25-2" class="reference"><a href="#cite_note-Tsai2010-25">[25]</a></sup> Early signs of systemic complement-mediated TMA include <a href="/wiki/Thrombocytopenia" title="Thrombocytopenia">thrombocytopenia</a> (platelet count below 150,000 or a decrease from baseline of at least 25%)<sup id="cite_ref-Caprioli2006_14-5" class="reference"><a href="#cite_note-Caprioli2006-14">[14]</a></sup> and evidence of <a href="/wiki/Microangiopathy" title="Microangiopathy">microangiopathic</a> hemolysis, which is characterized by elevated LDH levels, decreased haptoglobin, decreased <a href="/wiki/Hemoglobin" title="Hemoglobin">hemoglobin</a>, and/or the presence of schistocytes.<sup id="cite_ref-Benz2010_7-5" class="reference"><a href="#cite_note-Benz2010-7">[7]</a></sup><sup id="cite_ref-Zipfel2010_8-3" class="reference"><a href="#cite_note-Zipfel2010-8">[8]</a></sup><sup id="cite_ref-Caprioli2006_14-6" class="reference"><a href="#cite_note-Caprioli2006-14">[14]</a></sup></p>
<h2><span class="mw-headline" id="Diagnosis">Diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hemolytic-uremic_syndrome&amp;action=edit&amp;section=4" title="Edit section: Diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The similarities between HUS, aHUS, and TTP make differential diagnosis essential.<sup id="cite_ref-Benz2010_7-6" class="reference"><a href="#cite_note-Benz2010-7">[7]</a></sup><sup id="cite_ref-Zipfel2010_8-4" class="reference"><a href="#cite_note-Zipfel2010-8">[8]</a></sup> All three of these systemic TMA-causing diseases are characterized by thrombocytopenia<sup id="cite_ref-Caprioli2006_14-7" class="reference"><a href="#cite_note-Caprioli2006-14">[14]</a></sup> and microangiopathic hemolysis,<sup id="cite_ref-Noris2009_6-5" class="reference"><a href="#cite_note-Noris2009-6">[6]</a></sup><sup id="cite_ref-Caprioli2006_14-8" class="reference"><a href="#cite_note-Caprioli2006-14">[14]</a></sup> plus one or more of the following: neurological symptoms (e.g., confusion,<sup id="cite_ref-Noris2009_6-6" class="reference"><a href="#cite_note-Noris2009-6">[6]</a></sup><sup id="cite_ref-Neuhaus1997_22-1" class="reference"><a href="#cite_note-Neuhaus1997-22">[22]</a></sup> cerebral convulsions,<sup id="cite_ref-Neuhaus1997_22-2" class="reference"><a href="#cite_note-Neuhaus1997-22">[22]</a></sup> seizures<sup id="cite_ref-Dragon2010_19-2" class="reference"><a href="#cite_note-Dragon2010-19">[19]</a></sup>); renal impairment<sup id="cite_ref-Caprioli2006_14-9" class="reference"><a href="#cite_note-Caprioli2006-14">[14]</a></sup> (e.g., elevated creatinine,<sup id="cite_ref-Ariceta2009_15-1" class="reference"><a href="#cite_note-Ariceta2009-15">[15]</a></sup> decreased estimated glomerular filtration rate [eGFR],<sup id="cite_ref-Ariceta2009_15-2" class="reference"><a href="#cite_note-Ariceta2009-15">[15]</a></sup> abnormal urinalysis<sup id="cite_ref-AlAkash2011_44-0" class="reference"><a href="#cite_note-AlAkash2011-44">[44]</a></sup> ); and gastrointestinal (GI) symptoms (e.g., diarrhea,<sup id="cite_ref-Noris2010_17-4" class="reference"><a href="#cite_note-Noris2010-17">[17]</a></sup><sup id="cite_ref-Zuber2011_20-3" class="reference"><a href="#cite_note-Zuber2011-20">[20]</a></sup> nausea/vomiting,<sup id="cite_ref-Dragon2010_19-3" class="reference"><a href="#cite_note-Dragon2010-19">[19]</a></sup> abdominal pain,<sup id="cite_ref-Dragon2010_19-4" class="reference"><a href="#cite_note-Dragon2010-19">[19]</a></sup> gastroenteritis<sup id="cite_ref-Caprioli2006_14-10" class="reference"><a href="#cite_note-Caprioli2006-14">[14]</a></sup><sup id="cite_ref-Noris2010_17-5" class="reference"><a href="#cite_note-Noris2010-17">[17]</a></sup>).The presence of diarrhea does not exclude aHUS as the etiology of TMA, as 28% of patients with aHUS present with diarrhea and/or gastroenteritis.<sup id="cite_ref-Sellier2007_16-4" class="reference"><a href="#cite_note-Sellier2007-16">[16]</a></sup><sup id="cite_ref-Noris2010_17-6" class="reference"><a href="#cite_note-Noris2010-17">[17]</a></sup> First diagnosis of aHUS is often made in the context of an initial, complement-triggering infection, and Shiga-toxin has also been implicated as a trigger that identifies patients with aHUS.<sup id="cite_ref-Mache2010_39-1" class="reference"><a href="#cite_note-Mache2010-39">[39]</a></sup> Additionally, in one study, mutations of genes encoding several complement regulatory proteins were detected in 8 of 36 (22%) patients diagnosed with STEC-HUS.<sup id="cite_ref-Gagnadoux1996_45-0" class="reference"><a href="#cite_note-Gagnadoux1996-45">[45]</a></sup> However, the absence of an identified complement regulatory gene mutation does not preclude aHUS as the etiology of the TMA, as approximately 50% of patients with aHUS lack an identifiable mutation in complement regulatory genes.<sup id="cite_ref-Noris2010_17-7" class="reference"><a href="#cite_note-Noris2010-17">[17]</a></sup></p>
<p>Diagnostic work-up supports the differential diagnosis of TMA-causing diseases. A positive Shiga-toxin/EHEC test confirms an etiological cause for STEC-HUS,<sup id="cite_ref-Noris2005_23-2" class="reference"><a href="#cite_note-Noris2005-23">[23]</a></sup><sup id="cite_ref-Palermo2009_31-1" class="reference"><a href="#cite_note-Palermo2009-31">[31]</a></sup> and severe <a href="/wiki/ADAMTS13" title="ADAMTS13">ADAMTS13</a> deficiency (i.e., 5% of normal ADAMTS13 levels) confirms a diagnosis of TTP.<sup id="cite_ref-Zheng2010_46-0" class="reference"><a href="#cite_note-Zheng2010-46">[46]</a></sup></p>
<h2><span class="mw-headline" id="Treatment">Treatment</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hemolytic-uremic_syndrome&amp;action=edit&amp;section=5" title="Edit section: Treatment">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The effect of antibiotics in <i>E. coli</i> O157:H7 colitis is controversial. Certain antibiotic may stimulate further verotoxin production and thereby increase the risk of HUS.<sup id="cite_ref-Tan2011_40-1" class="reference"><a href="#cite_note-Tan2011-40">[40]</a></sup><sup id="cite_ref-pmid16918877_47-0" class="reference"><a href="#cite_note-pmid16918877-47">[47]</a></sup> However, there is also tentative evidence that some antibiotics like <a href="/wiki/Quinolones" title="Quinolones" class="mw-redirect">quinolones</a> may decrease the risk of hemolytic uremic syndrome.<sup id="cite_ref-pmid16918877_47-1" class="reference"><a href="#cite_note-pmid16918877-47">[47]</a></sup> In the 1990s a group of pediatricians from the University of Washington used a network of 47 cooperating laboratories in Washington, Oregon, Idaho, and Wyoming to prospectively identify 73 children younger than 10 years of age who had diarrhea caused by <i>E. coli</i> O157:H7 The hemolyticuremic syndrome developed in 5 of the 9 children given antibiotics (56 percent), and in 5 of the 62 children who were not given antibiotics (8 percent, P&lt;0.001). N Eng J Med 2000: 342:1930-1936 June 29, 2000. The risk of Hemolytic Uremic syndrome after antibiotic treatment of escherichia coli O157:H7 infections. Craig S. Wong, M.D., Srdjan Jelacic, B.S., Rebecca L. Habeeb, B.S., Sandra L. Watkins, M.D., and Phillip I. Tarr, M.D. N Engl J Med 2000; 342:1930-1936June 29, 2000</p>
<p>Treatment of HUS is generally supportive, with <a href="/wiki/Dialysis" title="Dialysis">dialysis</a> as needed. <a href="/wiki/Platelet" title="Platelet">Platelet</a> <a href="/wiki/Blood_transfusion" title="Blood transfusion">transfusion</a> may actually worsen the outcome.</p>
<p>In most children with postdiarrheal HUS, there is a good chance of spontaneous resolution, so observation in a hospital is often all that is necessary, with supportive care such as <a href="/wiki/Hemodialysis" title="Hemodialysis">hemodialysis</a> where indicated. If a diagnosis of STEC-HUS is confirmed, <a href="/wiki/Plasmapheresis" title="Plasmapheresis">plasmapheresis</a> (plasma exchange) is contraindicated. However, plasmapheresis may be indicated when there is diagnostic uncertainty between HUS and TTP.</p>
<p>There are case reports of experimental treatments with <a href="/wiki/Eculizumab" title="Eculizumab">eculizumab</a>, a <a href="/wiki/Monoclonal_antibody" title="Monoclonal antibody">monoclonal antibody</a> that blocks part of the <a href="/wiki/Complement_system" title="Complement system">complement system</a>, being used to treat congenital atypical hemolytic uremic syndrome,<sup id="cite_ref-48" class="reference"><a href="#cite_note-48">[48]</a></sup> as well as severe shiga-toxin associated hemolytic uremic syndrome.<sup id="cite_ref-49" class="reference"><a href="#cite_note-49">[49]</a></sup> These have shown promising results. Eculizumab was approved by the U.S. Food and Drug Administration (FDA) on March 13, 2007 for the treatment of <a href="/wiki/Paroxysmal_nocturnal_hemoglobinuria" title="Paroxysmal nocturnal hemoglobinuria">paroxysmal nocturnal hemoglobinuria</a> (PNH), a rare, progressive, and sometimes life-threatening disease characterized by excessive hemolysis; and on September 23, 2011 for the treatment of atypical hemolytic uremic syndrome (aHUS) It was approved by the European Medicines Agency for the treatment of PNH on June 20, 2007, and on November 29, 2011 for the treatment of aHUS. However, of note is the exceedingly high cost of treatment, with one year of the drug costing over $500,000.</p>
<h2><span class="mw-headline" id="Prognosis">Prognosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hemolytic-uremic_syndrome&amp;action=edit&amp;section=6" title="Edit section: Prognosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Acute renal failure occurs in 55-70% of patients with STEC-HUS, although up to 70-85% recover renal function.<sup id="cite_ref-Parmar2010_50-0" class="reference"><a href="#cite_note-Parmar2010-50">[50]</a></sup> Patients with aHUS generally have poor outcomes, with up to 50% progressing to ESRD or irreversible brain damage; as many as 25% die during the acute phase.<sup id="cite_ref-Parmar2010_50-1" class="reference"><a href="#cite_note-Parmar2010-50">[50]</a></sup> However, with aggressive treatment, more than 90% of patients survive the acute phase of HUS, and only about 9% may develop ESRD. Roughly one-third of persons with HUS have abnormal kidney function many years later, and a few require long-term dialysis. Another 8% of persons with HUS have other lifelong complications, such as high blood pressure, seizures, blindness, paralysis, and the effects of having part of their colon removed. The overall mortality rate from HUS is 5-15%. Children and the elderly have a worse prognosis.<sup id="cite_ref-Chu2004_51-0" class="reference"><a href="#cite_note-Chu2004-51">[51]</a></sup></p>
<h2><span class="mw-headline" id="Epidemiology">Epidemiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hemolytic-uremic_syndrome&amp;action=edit&amp;section=7" title="Edit section: Epidemiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The country with the highest incidence of HUS is Argentina<sup id="cite_ref-pmid21492023_52-0" class="reference"><a href="#cite_note-pmid21492023-52">[52]</a></sup><sup id="cite_ref-pmid14531383_53-0" class="reference"><a href="#cite_note-pmid14531383-53">[53]</a></sup><sup id="cite_ref-pmid15338982_54-0" class="reference"><a href="#cite_note-pmid15338982-54">[54]</a></sup><sup id="cite_ref-55" class="reference"><a href="#cite_note-55">[55]</a></sup> and it performs a key role in the research of this condition.</p>
<p>In the United States, the overall incidence of HUS is estimated at 2.1 cases per 100,000 persons/year, with a peak incidence between six months and four years of age.<sup id="cite_ref-pmid11691946_1-1" class="reference"><a href="#cite_note-pmid11691946-1">[1]</a></sup></p>
<p>HUS and the <i>E. coli</i> infections that cause it have been the source of much negative publicity for the FDA, meat industries, and fast-food restaurants since the 1990s, especially in the contaminations linked to Jack in the Box restaurants. The disease was also featured in the <a href="/wiki/Toxin_(novel)" title="Toxin (novel)">Robin Cook novel Toxin</a>. In 2006, an epidemic of harmful <i>E. coli</i> emerged in the United States due to contaminated spinach. In June, 2009, Nestle Toll House cookie dough was linked to an outbreak of <i>E. coli</i> 0157:H7 in the United States, which sickened 70 people in 30 states.<sup id="cite_ref-pmid11691946_1-2" class="reference"><a href="#cite_note-pmid11691946-1">[1]</a></sup></p>
<p>In May, 2011 an epidemic of bloody diarrhea caused by <i>E. coli</i> O104:H4-contaminated fenugreek seeds hit Germany. Tracing the epidemic revealed more than 3,800 cases, with HUS developing in more than 800 of the cases, including 36 fatal cases. Nearly 90% of the HUS cases were in adults.<sup id="cite_ref-Buchholz_56-0" class="reference"><a href="#cite_note-Buchholz-56">[56]</a></sup><sup id="cite_ref-57" class="reference"><a href="#cite_note-57">[57]</a></sup> In response to the crisis, <a href="/wiki/Alexion_Pharmaceuticals" title="Alexion Pharmaceuticals">Alexion Pharmaceuticals</a>, Inc., the makers of Soliris (eculizumab), initiated of an open-label clinical trial to investigate eculizumab as a treatment for patients with Shiga-toxin-producing <i>E. coli</i> hemolytic uremic syndrome (STEC-HUS). Alexion also initiated an eculizumab access program whereby the company provided eculizumab free of charge throughout the crisis. The study was designed to include all patients treated with eculizumab during the 2011 STEC-HUS outbreak.<sup id="cite_ref-Alexion_58-0" class="reference"><a href="#cite_note-Alexion-58">[58]</a></sup></p>
<h2><span class="mw-headline" id="See_also">See also</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hemolytic-uremic_syndrome&amp;action=edit&amp;section=8" title="Edit section: See also">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li><a href="/wiki/Thrombotic_thrombocytopenic_purpura" title="Thrombotic thrombocytopenic purpura">Thrombotic thrombocytopenic purpura</a></li>
<li><a href="/wiki/Shigellosis" title="Shigellosis">Shigellosis</a></li>
<li><a href="/wiki/Microangiopathic_hemolytic_anemia" title="Microangiopathic hemolytic anemia">Microangiopathic hemolytic anemia</a></li>
</ul>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hemolytic-uremic_syndrome&amp;action=edit&amp;section=9" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist columns references-column-count references-column-count-2" style="-moz-column-count: 2; -webkit-column-count: 2; column-count: 2; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-pmid11691946-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid11691946_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid11691946_1-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid11691946_1-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Corrigan JJ, Boineau FG (November 2001). "Hemolytic-uremic syndrome". <i>Pediatr Rev</i> <b>22</b> (11): 3659. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11691946">11691946</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Hemolytic-uremic+syndrome&amp;rft.au=Corrigan+JJ%2C+Boineau+FG&amp;rft.date=2001-11&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F11691946&amp;rft.issue=11&amp;rft.jtitle=Pediatr+Rev&amp;rft.pages=365-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=22" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid1816053-2"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid1816053_2-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Anagnou NP, Papanicolaou N, Fessas P (1991). "Recurrent attacks of hemolytic uremic syndrome". <i>Haematologia (Budap)</i> <b>24</b> (2): 1015. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1816053">1816053</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Recurrent+attacks+of+hemolytic+uremic+syndrome&amp;rft.au=Anagnou+NP%2C+Papanicolaou+N%2C+Fessas+P&amp;rft.date=1991&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F1816053&amp;rft.issue=2&amp;rft.jtitle=Haematologia+%28Budap%29&amp;rft.pages=101-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=24" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Multiple names: authors list (<a href="/wiki/Category:CS1_maint:_Multiple_names:_authors_list" title="Category:CS1 maint: Multiple names: authors list">link</a>)</span></span></li>
<li id="cite_note-pmid13274004-3"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid13274004_3-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Gasser C, Gautier E, Steck A, Siebenmann RE, Oechslin R (September 1955). "Hemolytic-uremic syndrome: bilateral necrosis of the renal cortex in acute acquired hemolytic anemia". <i>Schweiz Med Wochenschr</i> (in German) <b>85</b> (3839): 9059. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/13274004">13274004</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Hemolytic-uremic+syndrome%3A++bilateral+necrosis+of+the+renal+cortex+in+acute+acquired+hemolytic+anemia&amp;rft.au=Gasser+C%2C+Gautier+E%2C+Steck+A%2C+Siebenmann+RE%2C+Oechslin+R&amp;rft.date=1955-09&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F13274004&amp;rft.issue=38%9339&amp;rft.jtitle=Schweiz+Med+Wochenschr&amp;rft.pages=905-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=85" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Multiple names: authors list (<a href="/wiki/Category:CS1_maint:_Multiple_names:_authors_list" title="Category:CS1 maint: Multiple names: authors list">link</a>)</span></span></li>
<li id="cite_note-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-4">^</a></b></span> <span class="reference-text">Robbins and Cotran pathologic basis of disease. (2010) (8th ed.). Philadelphia, PA: Saunders/Elsevier.</span></li>
<li id="cite_note-Shimizu2012-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-Shimizu2012_5-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Shimizu, M; Yokoyama, T; Sakashita, N; Sato, A; Ueno, K; Akita, C; Ohta, K; Kitano, E; Hatanaka, M; Kitamura, H; Saikawa, Y; Yachie, A (October 2012). "Thomsen-Friedenreich antigen exposure as a cause of Streptococcus pyogenes-associated hemolytic-uremic syndrome". <i>Clinical nephrology</i> <b>78</b> (4): 32831. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.5414%2FCN107205">10.5414/CN107205</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22981036">22981036</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Thomsen-Friedenreich+antigen+exposure+as+a+cause+of+Streptococcus+pyogenes-associated+hemolytic-uremic+syndrome&amp;rft.aufirst=M&amp;rft.aulast=Shimizu&amp;rft.au=Yokoyama%2C+T%3B+Sakashita%2C+N%3B+Sato%2C+A%3B+Ueno%2C+K%3B+Akita%2C+C%3B+Ohta%2C+K%3B+Kitano%2C+E%3B+Hatanaka%2C+M%3B+Kitamura%2C+H%3B+Saikawa%2C+Y%3B+Yachie%2C+A&amp;rft.date=2012-10&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.5414%2FCN107205&amp;rft_id=info%3Apmid%2F22981036&amp;rft.issue=4&amp;rft.jtitle=Clinical+nephrology&amp;rft.pages=328-31&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=78" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Multiple names: authors list (<a href="/wiki/Category:CS1_maint:_Multiple_names:_authors_list" title="Category:CS1 maint: Multiple names: authors list">link</a>)</span></span></li>
<li id="cite_note-Noris2009-6"><span class="mw-cite-backlink">^ <a href="#cite_ref-Noris2009_6-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Noris2009_6-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Noris2009_6-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Noris2009_6-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Noris2009_6-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Noris2009_6-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Noris2009_6-6"><sup><i><b>g</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Noris, M; Remuzzi, G (2009). "Atypical hemolytic-uremic syndrome". <i><a href="/wiki/N_Engl_J_Med" title="N Engl J Med" class="mw-redirect">N Engl J Med</a></i> <b>361</b> (17): 16761687. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJMra0902814">10.1056/NEJMra0902814</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19846853">19846853</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Atypical+hemolytic-uremic+syndrome&amp;rft.aufirst=M&amp;rft.aulast=Noris&amp;rft.au=Remuzzi%2C+G&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMra0902814&amp;rft_id=info%3Apmid%2F19846853&amp;rft.issue=17&amp;rft.jtitle=N+Engl+J+Med&amp;rft.pages=1676-1687&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=361" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Benz2010-7"><span class="mw-cite-backlink">^ <a href="#cite_ref-Benz2010_7-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Benz2010_7-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Benz2010_7-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Benz2010_7-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Benz2010_7-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Benz2010_7-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Benz2010_7-6"><sup><i><b>g</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Benz, K; Amann, K (2010). "Thrombotic microangiopathy: new insights". <i>Current Opinion in Nephrology and Hypertension</i> <b>19</b> (3): 242247. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1097%2FMNH.0b013e3283378f25">10.1097/MNH.0b013e3283378f25</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20186056">20186056</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Thrombotic+microangiopathy%3A+new+insights&amp;rft.au=Amann%2C+K&amp;rft.aufirst=K&amp;rft.aulast=Benz&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2FMNH.0b013e3283378f25&amp;rft_id=info%3Apmid%2F20186056&amp;rft.issue=3&amp;rft.jtitle=Current+Opinion+in+Nephrology+and+Hypertension&amp;rft.pages=242-247&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=19" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Zipfel2010-8"><span class="mw-cite-backlink">^ <a href="#cite_ref-Zipfel2010_8-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Zipfel2010_8-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Zipfel2010_8-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Zipfel2010_8-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Zipfel2010_8-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Zipfel, PF; Heinen, S; Skerka, C (2010). "Thrombotic microangiopathies: new insights and new challenges". <i>Current Opinion in Nephrology and Hypertension</i> <b>19</b> (4): 372378. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1097%2FMNH.0b013e32833aff4a">10.1097/MNH.0b013e32833aff4a</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20539230">20539230</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Thrombotic+microangiopathies%3A+new+insights+and+new+challenges&amp;rft.aufirst=PF&amp;rft.au=Heinen%2C+S&amp;rft.aulast=Zipfel&amp;rft.au=Skerka%2C+C&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2FMNH.0b013e32833aff4a&amp;rft_id=info%3Apmid%2F20539230&amp;rft.issue=4&amp;rft.jtitle=Current+Opinion+in+Nephrology+and+Hypertension&amp;rft.pages=372-378&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=19" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Boyer2011-9"><span class="mw-cite-backlink">^ <a href="#cite_ref-Boyer2011_9-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Boyer2011_9-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Boyer, O; Niaudet, P (August 2011). <a rel="nofollow" class="external text" href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=3159990">"Hemolytic Uremic Syndrome: New Developments in Pathogenesis and Treatments"</a>. <i>Int J Nephrol</i> <b>2011</b>: 908407. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.4061%2F2011%2F908407">10.4061/2011/908407</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>:&#160;3159990. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21876803">21876803</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Hemolytic+Uremic+Syndrome%3A+New+Developments+in+Pathogenesis+and+Treatments&amp;rft.aufirst=O&amp;rft.aulast=Boyer&amp;rft.au=Niaudet%2C+P&amp;rft.date=2011-08&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3159990&amp;rft_id=http%3A%2F%2Fwww.pubmedcentral.nih.gov%2Farticlerender.fcgi%3Ftool%3Dpmcentrez%26artid%3D3159990&amp;rft_id=info%3Adoi%2F10.4061%2F2011%2F908407&amp;rft_id=info%3Apmid%2F21876803&amp;rft.jtitle=Int+J+Nephrol&amp;rft.pages=908407&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=2011" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Kumar2002-10"><span class="mw-cite-backlink">^ <a href="#cite_ref-Kumar2002_10-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Kumar2002_10-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation book">Kumar, V; Cotran, RS; Robbins, SL, eds. (2002). <i>Robbins Basic Pathology</i>. Philadelphia, PA: Saunders. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0721692745" title="Special:BookSources/0721692745">0721692745</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.btitle=Robbins+Basic+Pathology&amp;rft.date=2002&amp;rft.genre=book&amp;rft.isbn=0721692745&amp;rft.place=Philadelphia%2C+PA&amp;rft.pub=Saunders&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Nathanson2010-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-Nathanson2010_11-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Nathanson, S.; Kwon, T.; Elmaleh, M.; et al. (2010). "Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome". <i>Clin J Am Soc Nephrol</i> <b>5</b> (7): 12181228. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.2215%2FCJN.08921209">10.2215/CJN.08921209</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>:&#160;2893076. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20498239">20498239</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Acute+neurological+involvement+in+diarrhea-associated+hemolytic+uremic+syndrome&amp;rft.au=Bandin%2C+F.&amp;rft.au=Bourdat-Michel%2C+G.&amp;rft.au=Brun%2C+M.&amp;rft.au=Champion%2C+G.&amp;rft.au=Charbit%2C+M.&amp;rft.au=Cloarec%2C+S.&amp;rft.au=Desch%C3%AAnes%2C+G.&amp;rft.au=Elmaleh%2C+M.&amp;rft.aufirst=S.&amp;rft.au=Harambat%2C+J.&amp;rft.au=Kwon%2C+T.&amp;rft.aulast=Nathanson&amp;rft.au=Launay%2C+E.+A.&amp;rft.au=Pi%C3%A8trement%2C+C.&amp;rft.au=Ranchin%2C+B.&amp;rft.au=Ulinski%2C+T.&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2893076&amp;rft_id=info%3Adoi%2F10.2215%2FCJN.08921209&amp;rft_id=info%3Apmid%2F20498239&amp;rft.issue=7&amp;rft.jtitle=Clin+J+Am+Soc+Nephrol&amp;rft.pages=1218-1228&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=5" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Ohanian2011-12"><span class="mw-cite-backlink">^ <a href="#cite_ref-Ohanian2011_12-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Ohanian2011_12-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Ohanian2011_12-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Ohanian, M; Cable, C; Halka, K (2011). "Eculizumab safely reverses neurologic impairment and eliminates the need for dialysis in severe atypical hemolytic uremic syndrome". <i>Clin Pharmacol</i> <b>3</b>: 512. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.2147%2FCPAA.S17904">10.2147/CPAA.S17904</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>:&#160;3262387. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22287852">22287852</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Eculizumab+safely+reverses+neurologic+impairment+and+eliminates+the+need+for+dialysis+in+severe+atypical+hemolytic+uremic+syndrome&amp;rft.au=Cable%2C+C&amp;rft.aufirst=M&amp;rft.au=Halka%2C+K&amp;rft.aulast=Ohanian&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3262387&amp;rft_id=info%3Adoi%2F10.2147%2FCPAA.S17904&amp;rft_id=info%3Apmid%2F22287852&amp;rft.jtitle=Clin+Pharmacol&amp;rft.pages=5-12&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=3" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Loirat2008-13"><span class="mw-cite-backlink">^ <a href="#cite_ref-Loirat2008_13-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Loirat2008_13-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Loirat2008_13-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Loirat2008_13-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Loirat2008_13-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Loirat, C; Noris, M; Fremaux-Bacchi, V (2008). "Complement and the atypical hemolytic uremia syndrome in children". <i>Pediatr Nephrol</i> <b>23</b> (11): 19571972. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2Fs00467-008-0872-4">10.1007/s00467-008-0872-4</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18594873">18594873</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Complement+and+the+atypical+hemolytic+uremia+syndrome+in+children&amp;rft.aufirst=C&amp;rft.au=Fremaux-Bacchi%2C+V&amp;rft.aulast=Loirat&amp;rft.au=Noris%2C+M&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs00467-008-0872-4&amp;rft_id=info%3Apmid%2F18594873&amp;rft.issue=11&amp;rft.jtitle=Pediatr+Nephrol&amp;rft.pages=1957-1972&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=23" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Caprioli2006-14"><span class="mw-cite-backlink">^ <a href="#cite_ref-Caprioli2006_14-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Caprioli2006_14-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Caprioli2006_14-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Caprioli2006_14-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Caprioli2006_14-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Caprioli2006_14-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Caprioli2006_14-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Caprioli2006_14-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Caprioli2006_14-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Caprioli2006_14-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Caprioli2006_14-10"><sup><i><b>k</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Caprioli, J.; Noris, M.; Brioschi, S.; et al. (2006). "Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome". <i>Blood</i> <b>108</b> (4): 12671279. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fblood-2005-10-007252">10.1182/blood-2005-10-007252</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>:&#160;1895874. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16621965">16621965</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Genetics+of+HUS%3A+the+impact+of+MCP%2C+CFH%2C+and+IF+mutations+on+clinical+presentation%2C+response+to+treatment%2C+and+outcome&amp;rft.au=Atkinson%2C+J.+P.&amp;rft.au=Bettinaglio%2C+P.&amp;rft.au=Bresin%2C+E.&amp;rft.au=Brioschi%2C+S.&amp;rft.au=Bucchioni%2C+S.&amp;rft.au=Cassis%2C+L.&amp;rft.au=Castelletti%2C+F.&amp;rft.au=Fang%2C+C.+J.&amp;rft.aufirst=J.&amp;rft.au=Gamba%2C+S.&amp;rft.au=Kavanagh%2C+D.&amp;rft.aulast=Caprioli&amp;rft.au=Liszewski%2C+M.+K.&amp;rft.au=Mele%2C+C.&amp;rft.au=Monteferrante%2C+G.&amp;rft.au=Noris%2C+M.&amp;rft.au=Pianetti%2C+G.&amp;rft.au=Porrati%2C+F.&amp;rft.au=Remuzzi%2C+G.&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1895874&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2005-10-007252&amp;rft_id=info%3Apmid%2F16621965&amp;rft.issue=4&amp;rft.jtitle=Blood&amp;rft.pages=1267-1279&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=108" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Ariceta2009-15"><span class="mw-cite-backlink">^ <a href="#cite_ref-Ariceta2009_15-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Ariceta2009_15-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Ariceta2009_15-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Ariceta, Gema; Besbas, Nesrin; Johnson, Sally; et al. (2009). "Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome". <i>Pediatr Nephrol</i> <b>24</b> (4): 687696. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2Fs00467-008-0964-1">10.1007/s00467-008-0964-1</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18800230">18800230</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Guideline+for+the+investigation+and+initial+therapy+of+diarrhea-negative+hemolytic+uremic+syndrome&amp;rft.au=Besbas%2C+Nesrin&amp;rft.aufirst=Gema&amp;rft.au=Johnson%2C+Sally&amp;rft.au=Karpman%2C+Diana&amp;rft.au=Landau%2C+Daniel&amp;rft.aulast=Ariceta&amp;rft.au=Licht%2C+Christoph&amp;rft.au=Loirat%2C+Chantal&amp;rft.au=Pecoraro%2C+Carmine&amp;rft.au=Taylor%2C+C.+Mark&amp;rft.au=Van+de+Kar%2C+Nicole&amp;rft.au=VandeWalle%2C+Johan&amp;rft.au=Zimmerhackl%2C+Lothar+B.&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs00467-008-0964-1&amp;rft_id=info%3Apmid%2F18800230&amp;rft.issue=4&amp;rft.jtitle=Pediatr+Nephrol&amp;rft.pages=687-696&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=24" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Sellier2007-16"><span class="mw-cite-backlink">^ <a href="#cite_ref-Sellier2007_16-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Sellier2007_16-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Sellier2007_16-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Sellier2007_16-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Sellier2007_16-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Sellier-Leclers, A.-L.; Fremeaux-Bacchi, V.; Dragon-Durey, M.-A.; et al. (2007). "Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome". <i>J Am Soc Nephrol</i> <b>18</b> (8): 23922400. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1681%2FASN.2006080811">10.1681/ASN.2006080811</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17599974">17599974</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Differential+impact+of+complement+mutations+on+clinical+characteristics+in+atypical+hemolytic+uremic+syndrome&amp;rft.au=Alberti%2C+C.&amp;rft.au=Boudailliez%2C+B.&amp;rft.au=Bouissou%2C+F.&amp;rft.au=Deschenes%2C+G.&amp;rft.au=Dragon-Durey%2C+M.-A.&amp;rft.aufirst=A.-L.&amp;rft.au=Fischbach%2C+M.&amp;rft.au=Fremeaux-Bacchi%2C+V.&amp;rft.au=Gie%2C+S.&amp;rft.au=Guest%2C+G.&amp;rft.aulast=Sellier-Leclers&amp;rft.au=Loirat%2C+C.&amp;rft.au=Macher%2C+M.-A.&amp;rft.au=Morin%2C+D.&amp;rft.au=Niaudet%2C+P.&amp;rft.au=Nivet%2C+H.&amp;rft.au=Tsimaratos%2C+M.&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1681%2FASN.2006080811&amp;rft_id=info%3Apmid%2F17599974&amp;rft.issue=8&amp;rft.jtitle=J+Am+Soc+Nephrol&amp;rft.pages=2392-2400&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=18" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Noris2010-17"><span class="mw-cite-backlink">^ <a href="#cite_ref-Noris2010_17-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Noris2010_17-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Noris2010_17-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Noris2010_17-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Noris2010_17-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Noris2010_17-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Noris2010_17-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Noris2010_17-7"><sup><i><b>h</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Noris, M.; Caprioli, J.; Bresin, E.; et al. (2010). "Relative role of genetic complement abnormalities in infrequent and familial aHUS and their impact on clinical phemotype". <i>Clin J Am Soc Nephrol</i> <b>5</b> (10): 18441859. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.2215%2FCJN.02210310">10.2215/CJN.02210310</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>:&#160;2974386. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20595690">20595690</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Relative+role+of+genetic+complement+abnormalities+in+infrequent+and+familial+aHUS+and+their+impact+on+clinical+phemotype&amp;rft.au=Bresin%2C+E.&amp;rft.au=Caprioli%2C+J.&amp;rft.au=Castelletti%2C+F.&amp;rft.au=Conway%2C+E.+M.&amp;rft.au=Daina%2C+E.&amp;rft.au=Donadelli%2C+R.&amp;rft.au=Fenili%2C+C.&amp;rft.aufirst=M.&amp;rft.au=Gamba%2C+S.&amp;rft.au=Goodship%2C+T.+H.&amp;rft.aulast=Noris&amp;rft.au=Maranta%2C+R.&amp;rft.au=Mossali%2C+C.&amp;rft.au=Pianetti%2C+G.&amp;rft.au=Piras%2C+R.&amp;rft.au=Remuzzi%2C+G.&amp;rft.au=Sorosina%2C+A.&amp;rft.au=van+der+Meer%2C+I.&amp;rft.au=Zipfel%2C+P.+F.&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2974386&amp;rft_id=info%3Adoi%2F10.2215%2FCJN.02210310&amp;rft_id=info%3Apmid%2F20595690&amp;rft.issue=10&amp;rft.jtitle=Clin+J+Am+Soc+Nephrol&amp;rft.pages=1844-1859&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=5" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Stahl2008-18"><span class="mw-cite-backlink">^ <a href="#cite_ref-Stahl2008_18-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Stahl2008_18-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Sthl, A.-L.; Vazir-Sani, F.; Heinen, S.; et al. (2008). "Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation". <i>Blood</i> <b>111</b> (11): 53075317. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fblood-2007-08-106153">10.1182/blood-2007-08-106153</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18268093">18268093</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Factor+H+dysfunction+in+patients+with+atypical+hemolytic+uremic+syndrome+contributes+to+complement+deposition+on+platelets+and+their+activation&amp;rft.au=Beringer%2C+O.&amp;rft.aufirst=A.-L.&amp;rft.au=Gutierrez%2C+A.&amp;rft.au=Gydell%2C+K.-H.&amp;rft.au=Heinen%2C+S.&amp;rft.au=Karpman%2C+D.&amp;rft.au=Kristoffersson%2C+A.-C.&amp;rft.aulast=St%C3%A5hl&amp;rft.au=Raafat%2C+R.&amp;rft.au=Vazir-Sani%2C+F.&amp;rft.au=Zipfel%2C+P.+F.&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2007-08-106153&amp;rft_id=info%3Apmid%2F18268093&amp;rft.issue=11&amp;rft.jtitle=Blood&amp;rft.pages=5307-5317&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=111" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Dragon2010-19"><span class="mw-cite-backlink">^ <a href="#cite_ref-Dragon2010_19-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Dragon2010_19-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Dragon2010_19-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Dragon2010_19-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Dragon2010_19-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Dragon-Durey, M.-A.; Sethi, S. K.; Bagga, A.; et al. (2010). "Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome". <i>J Am Soc Nephrol</i> <b>21</b> (12): 21802187. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1681%2FASN.2010030315">10.1681/ASN.2010030315</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>:&#160;3014031. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21051740">21051740</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Clinical+features+of+anti-factor+H+autoantibody-associated+hemolytic+uremic+syndrome&amp;rft.au=Andr%C3%A9%2C+J.-L.&amp;rft.au=Bagga%2C+A.&amp;rft.au=Blanc%2C+C.&amp;rft.au=Blouin%2C+J.&amp;rft.au=Cheong%2C+H.%2C+II&amp;rft.aufirst=M.-A.&amp;rft.au=Fr%C3%A9meaux-Bacchi%2C+V.&amp;rft.au=Fridman%2C+W.+H.&amp;rft.au=Hari%2C+P.&amp;rft.aulast=Dragon-Durey&amp;rft.au=Le+Quintrec%2C+M.&amp;rft.au=Loirat%2C+C.&amp;rft.au=Niaudet%2C+P.&amp;rft.au=Ranchin%2C+B.&amp;rft.au=Sethi%2C+S.+K.&amp;rft.au=Takagi%2C+N.&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3014031&amp;rft_id=info%3Adoi%2F10.1681%2FASN.2010030315&amp;rft_id=info%3Apmid%2F21051740&amp;rft.issue=12&amp;rft.jtitle=J+Am+Soc+Nephrol&amp;rft.pages=2180-2187&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=21" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Zuber2011-20"><span class="mw-cite-backlink">^ <a href="#cite_ref-Zuber2011_20-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Zuber2011_20-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Zuber2011_20-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Zuber2011_20-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Zuber, J; Le Quintrec, M; Sberro-Scussan, R; Loirat, C; Fremaux-Bacchi, V; Legendre, C (2011). "New insights into postrenal transplant hemolytic uremic syndrome". <i>Nature Reviews Nephrology</i> <b>7</b> (1): 2335. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fnrneph.2010.155">10.1038/nrneph.2010.155</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21102542">21102542</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=New+insights+into+postrenal+transplant+hemolytic+uremic+syndrome&amp;rft.aufirst=J&amp;rft.au=Fremaux-Bacchi%2C+V&amp;rft.aulast=Zuber&amp;rft.au=Legendre%2C+C&amp;rft.au=Le+Quintrec%2C+M&amp;rft.au=Loirat%2C+C&amp;rft.au=Sberro-Scussan%2C+R&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fnrneph.2010.155&amp;rft_id=info%3Apmid%2F21102542&amp;rft.issue=1&amp;rft.jtitle=Nature+Reviews+Nephrology&amp;rft.pages=23-35&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=7" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Sallee2010-21"><span class="mw-cite-backlink">^ <a href="#cite_ref-Sallee2010_21-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Sallee2010_21-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Sallee2010_21-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Sallee, M; et al. (2010). "Myocardial infarction is a complication of factor H-associated atypical HUS". <i>Nephrol Dial Transplant</i> <b>25</b> (6): 20282032. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1093%2Fndt%2Fgfq160">10.1093/ndt/gfq160</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20305136">20305136</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Myocardial+infarction+is+a+complication+of+factor+H-associated+atypical+HUS&amp;rft.au=Daniel%2C+L&amp;rft.aufirst=M&amp;rft.aulast=Sallee&amp;rft.au=Piercecchi%2C+M-D&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Fndt%2Fgfq160&amp;rft_id=info%3Apmid%2F20305136&amp;rft.issue=6&amp;rft.jtitle=Nephrol+Dial+Transplant&amp;rft.pages=2028-2032&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=25" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Neuhaus1997-22"><span class="mw-cite-backlink">^ <a href="#cite_ref-Neuhaus1997_22-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Neuhaus1997_22-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Neuhaus1997_22-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Neuhaus, TJ; Calonder, S; Leumann, EP (1997). "Heterogeneity of atypical haemolytic uraemis syndromes". <i>Arch Dis Child</i> <b>76</b> (6): 518521. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1136%2Fadc.76.6.518">10.1136/adc.76.6.518</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>:&#160;1717216. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9245850">9245850</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Heterogeneity+of+atypical+haemolytic+uraemis+syndromes&amp;rft.au=Calonder%2C+S&amp;rft.aufirst=TJ&amp;rft.aulast=Neuhaus&amp;rft.au=Leumann%2C+EP&amp;rft.date=1997&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1717216&amp;rft_id=info%3Adoi%2F10.1136%2Fadc.76.6.518&amp;rft_id=info%3Apmid%2F9245850&amp;rft.issue=6&amp;rft.jtitle=Arch+Dis+Child&amp;rft.pages=518-521&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=76" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Noris2005-23"><span class="mw-cite-backlink">^ <a href="#cite_ref-Noris2005_23-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Noris2005_23-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Noris2005_23-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Noris, M; Remuzzi, G (2005). "Hemolytic uremic syndrome". <i>J Am Soc Nephrol</i> <b>16</b> (4): 10351050. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1681%2FASN.2004100861">10.1681/ASN.2004100861</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15728781">15728781</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Hemolytic+uremic+syndrome&amp;rft.aufirst=M&amp;rft.aulast=Noris&amp;rft.au=Remuzzi%2C+G&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1681%2FASN.2004100861&amp;rft_id=info%3Apmid%2F15728781&amp;rft.issue=4&amp;rft.jtitle=J+Am+Soc+Nephrol&amp;rft.pages=1035-1050&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=16" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Mache2009-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-Mache2009_24-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Mache, CJ; et al. (2009). "Complement inhibitor eculizumab in atypical hemolytic uremic syndrome". <i>Clin J Amer Soc Nephrol</i> <b>4</b> (8): 13121316. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.2215%2FCJN.01090209">10.2215/CJN.01090209</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Complement+inhibitor+eculizumab+in+atypical+hemolytic+uremic+syndrome&amp;rft.au=Acham-Roschitz%2C+B&amp;rft.aufirst=CJ&amp;rft.au=Fremeaux-Bacchi%2C+V&amp;rft.aulast=Mache&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.2215%2FCJN.01090209&amp;rft.issue=8&amp;rft.jtitle=Clin+J+Amer+Soc+Nephrol&amp;rft.pages=1312-1316&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=4" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Tsai2010-25"><span class="mw-cite-backlink">^ <a href="#cite_ref-Tsai2010_25-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Tsai2010_25-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Tsai2010_25-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Tsai, H-M (2010). "Pathophysiology of thrombotic thrombocytopenic purpura". <i>Int J Hematol</i> <b>91</b> (1): 119. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2Fs12185-009-0476-1">10.1007/s12185-009-0476-1</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>:&#160;3159000. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20058209">20058209</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Pathophysiology+of+thrombotic+thrombocytopenic+purpura&amp;rft.aufirst=H-M&amp;rft.aulast=Tsai&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3159000&amp;rft_id=info%3Adoi%2F10.1007%2Fs12185-009-0476-1&amp;rft_id=info%3Apmid%2F20058209&amp;rft.issue=1&amp;rft.jtitle=Int+J+Hematol&amp;rft.pages=1-19&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=91" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-George2010-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-George2010_26-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">George, JN (2010). "How I treat my patients with thrombotic thrombocytopenic purpura". <i>Blood</i> <b>116</b> (20): 40604069. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fblood-2010-07-271445">10.1182/blood-2010-07-271445</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20686117">20686117</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=How+I+treat+my+patients+with+thrombotic+thrombocytopenic+purpura&amp;rft.aufirst=JN&amp;rft.aulast=George&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2010-07-271445&amp;rft_id=info%3Apmid%2F20686117&amp;rft.issue=20&amp;rft.jtitle=Blood&amp;rft.pages=4060-4069&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=116" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Michon2007-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-Michon2007_27-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Michon, B; et al. (2007). "Complications of apheresis in children". <i>Transfusion</i> <b>47</b> (10): 18371842. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1537-2995.2007.01405.x">10.1111/j.1537-2995.2007.01405.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17880609">17880609</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Complications+of+apheresis+in+children&amp;rft.aufirst=B&amp;rft.aulast=Michon&amp;rft.au=Moghrabi%2C+A&amp;rft.au=Winikoff%2C+R&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1537-2995.2007.01405.x&amp;rft_id=info%3Apmid%2F17880609&amp;rft.issue=10&amp;rft.jtitle=Transfusion&amp;rft.pages=1837-1842&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=47" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Collins2010-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-Collins2010_28-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Collins, Allan J.; et al. (2010). "Excerpts from the US Renal Data System 2009 Annual Data Report". <i>Am J Kidney Dis</i> <b>55</b>: S1S7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1053%2Fj.ajkd.2009.10.009">10.1053/j.ajkd.2009.10.009</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Excerpts+from+the+US+Renal+Data+System+2009+Annual+Data+Report&amp;rft.au=Chavers%2C+Blanche+M.&amp;rft.aufirst=Allan+J.&amp;rft.au=Foley%2C+Robert+N.&amp;rft.au=Gilbertson%2C+David&amp;rft.au=Herzog%2C+Charles&amp;rft.au=Ishani%2C+Areef&amp;rft.au=Kasiske%2C+Bertram+L.&amp;rft.aulast=Collins&amp;rft.au=Liu%2C+Jiannong&amp;rft.au=Mau%2C+Lih-Wen&amp;rft.au=McBean%2C+Marshall&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1053%2Fj.ajkd.2009.10.009&amp;rft.jtitle=Am+J+Kidney+Dis&amp;rft.pages=S1-S7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=55" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-European-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-European_29-0">^</a></b></span> <span class="reference-text"><cite class="citation book">European Renal Association- European Dialysis and Transplant Association Registry (2011). <i>ERA-EDTA Registry Annual Report 2009</i>. Amsterdam, The Netherlands: Academic Medical Center Department of Medical Informatics.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.au=European+Renal+Association-+European+Dialysis+and+Transplant+Association+Registry&amp;rft.btitle=ERA-EDTA+Registry+Annual+Report+2009&amp;rft.date=2011&amp;rft.genre=book&amp;rft.place=Amsterdam%2C+The+Netherlands&amp;rft.pub=Academic+Medical+Center+Department+of+Medical+Informatics&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Soliris-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-Soliris_30-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.soliris.net/sites/default/files/assets/soliris)pi.pdf">"Soliris (eculizumab) prescribing information"</a> <span style="font-size:85%;">(PDF)</span>. Cheshire, CT: Alexion Pharmaceuticals. 2011.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.btitle=Soliris+%28eculizumab%29+prescribing+information&amp;rft.date=2011&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.soliris.net%2Fsites%2Fdefault%2Ffiles%2Fassets%2Fsoliris%29pi.pdf&amp;rft.place=Cheshire%2C+CT%3A+Alexion+Pharmaceuticals&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Palermo2009-31"><span class="mw-cite-backlink">^ <a href="#cite_ref-Palermo2009_31-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Palermo2009_31-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Palermo, MS; Exeni, RA; Fernandez, GC (2009). "Hemolytic Uremic Syndrome: pathogenesis and update of interventions". <i>Expert Rev Anti Infect Ther</i> <b>7</b> (6): 697707. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1586%2Feri.09.49">10.1586/eri.09.49</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19681698">19681698</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Hemolytic+Uremic+Syndrome%3A+pathogenesis+and+update+of+interventions&amp;rft.au=Exeni%2C+RA&amp;rft.au=Fernandez%2C+GC&amp;rft.aufirst=MS&amp;rft.aulast=Palermo&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1586%2Feri.09.49&amp;rft_id=info%3Apmid%2F19681698&amp;rft.issue=6&amp;rft.jtitle=Expert+Rev+Anti+Infect+Ther&amp;rft.pages=697-707&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=7" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Robert-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-Robert_32-0">^</a></b></span> <span class="reference-text"><cite class="citation web">Robert Koch Institute. <a rel="nofollow" class="external text" href="http://www.rki.de/EN/Home/EHEC_Report.pdf?__blob=publicationFile.">"Technical Report: EHEC/HUS O104:H4 Outbreak, Germany, May/June 2011"</a> <span style="font-size:85%;">(PDF)</span>. Berlin, Germany: Robert Koch Institute.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.au=Robert+Koch+Institute&amp;rft.btitle=Technical+Report%3A+EHEC%2FHUS+O104%3AH4+Outbreak%2C+Germany%2C+May%2FJune+2011&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.rki.de%2FEN%2FHome%2FEHEC_Report.pdf%3F__blob%3DpublicationFile.&amp;rft.place=Berlin%2C+Germany&amp;rft.pub=Robert+Koch+Institute&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Psotka2009-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-Psotka2009_33-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Psotka, MA; et al. (2009). "Shiga toxin 2 targets the murine renal collecting duct epithelium". <i>Infect Immun</i> <b>77</b> (3): 959969. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1128%2FIAI.00679-08">10.1128/IAI.00679-08</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>:&#160;2643625. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19124603">19124603</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Shiga+toxin+2+targets+the+murine+renal+collecting+duct+epithelium&amp;rft.aufirst=MA&amp;rft.au=Kolling%2C+GL&amp;rft.aulast=Psotka&amp;rft.au=Obata%2C+F&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2643625&amp;rft_id=info%3Adoi%2F10.1128%2FIAI.00679-08&amp;rft_id=info%3Apmid%2F19124603&amp;rft.issue=3&amp;rft.jtitle=Infect+Immun&amp;rft.pages=959-969&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=77" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Zoja2010-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-Zoja2010_34-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Zoja, C; Buelli, S; Morigi, M (2010). "Shoga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction". <i>Pediatr Nephrol</i> <b>25</b> (11): 22312240. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2Fs00467-010-1522-1">10.1007/s00467-010-1522-1</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20424866">20424866</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Shoga+toxin-associated+hemolytic+uremic+syndrome%3A+pathophysiology+of+endothelial+dysfunction&amp;rft.au=Buelli%2C+S&amp;rft.aufirst=C&amp;rft.aulast=Zoja&amp;rft.au=Morigi%2C+M&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs00467-010-1522-1&amp;rft_id=info%3Apmid%2F20424866&amp;rft.issue=11&amp;rft.jtitle=Pediatr+Nephrol&amp;rft.pages=2231-2240&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=25" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Guessous2005-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-Guessous2005_35-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Guessous, F; et al. (2005). "Shiga toxin 2 and lipopolysaccharide induce human microvascular endothelial cells to release chemokines and factor that stimulate platelet function". <i>Infect Immun</i> <b>73</b> (12): 83068316. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1128%2FIAI.73.12.8306-8316.2005">10.1128/IAI.73.12.8306-8316.2005</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>:&#160;1307066. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16299328">16299328</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Shiga+toxin+2+and+lipopolysaccharide+induce+human+microvascular+endothelial+cells+to+release+chemokines+and+factor+that+stimulate+platelet+function&amp;rft.aufirst=F&amp;rft.au=Gear%2C+A&amp;rft.au=Heatherly%2C+D&amp;rft.au=Kongkhum%2C+S&amp;rft.aulast=Guessous&amp;rft.au=Marcinkiewicz%2C+M&amp;rft.au=Obrig%2C+T&amp;rft.au=Polanowska-Grabowska%2C+R&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1307066&amp;rft_id=info%3Adoi%2F10.1128%2FIAI.73.12.8306-8316.2005&amp;rft_id=info%3Apmid%2F16299328&amp;rft.issue=12&amp;rft.jtitle=Infect+Immun&amp;rft.pages=8306-8316&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=73" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Orth2010-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-Orth2010_36-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Orth, D; Wrzner, R (2010). "Complement in typical hemolytic uremic syndrome". <i>Semin thromb Hemost</i> <b>36</b> (3): 620624. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1055%2Fs-0030-1262883">10.1055/s-0030-1262883</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Complement+in+typical+hemolytic+uremic+syndrome&amp;rft.aufirst=D&amp;rft.aulast=Orth&amp;rft.au=W%C3%BCrzner%2C+R&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1055%2Fs-0030-1262883&amp;rft.issue=3&amp;rft.jtitle=Semin+thromb+Hemost&amp;rft.pages=620-624&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=36" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Stahl2011-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-Stahl2011_37-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Stahl, AL; Startz, L; Karpman, D (2011). "Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome". <i>Blood</i> <b>117</b> (20): 55035513. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fblood-2010-09-309161">10.1182/blood-2010-09-309161</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21447825">21447825</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Complement+activation+on+platelet-leukocyte+complexes+and+microparticles+in+enterohemorrhagic+Escherichia+coli-induced+hemolytic+uremic+syndrome&amp;rft.aufirst=AL&amp;rft.au=Karpman%2C+D&amp;rft.aulast=Stahl&amp;rft.au=Startz%2C+L&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2010-09-309161&amp;rft_id=info%3Apmid%2F21447825&amp;rft.issue=20&amp;rft.jtitle=Blood&amp;rft.pages=5503-5513&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=117" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Thurman2009-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-Thurman2009_38-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Thurman, J.M.; et al. (2009). "Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome". <i>Clin J Am Soc Nephrol</i> <b>4</b> (12): 19201924. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.2215%2FCJN.02730409">10.2215/CJN.02730409</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>:&#160;2798880. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19820137">19820137</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Alternative+pathway+of+complement+in+children+with+diarrhea-associated+hemolytic+uremic+syndrome&amp;rft.au=Emlen%2C+W.&amp;rft.aufirst=J.M.&amp;rft.aulast=Thurman&amp;rft.au=Marians%2C+R.&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2798880&amp;rft_id=info%3Adoi%2F10.2215%2FCJN.02730409&amp;rft_id=info%3Apmid%2F19820137&amp;rft.issue=12&amp;rft.jtitle=Clin+J+Am+Soc+Nephrol&amp;rft.pages=1920-1924&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=4" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Mache2010-39"><span class="mw-cite-backlink">^ <a href="#cite_ref-Mache2010_39-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Mache2010_39-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Mache, C; et al. (June 2010). "Eculizumab in diarrhea-associated hemolytic uremic syndrome". <i>Presented at the 2nd International Conference on HUS-MPGN-PNH</i> (Innsbruck, Austria).</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Eculizumab+in+diarrhea-associated+hemolytic+uremic+syndrome&amp;rft.aufirst=C&amp;rft.au=Gross%2C+B&amp;rft.aulast=Mache&amp;rft.au=Otto%2C+R&amp;rft.date=2010-06&amp;rft.genre=article&amp;rft.jtitle=Presented+at+the+2nd+International+Conference+on+HUS-MPGN-PNH&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Tan2011-40"><span class="mw-cite-backlink">^ <a href="#cite_ref-Tan2011_40-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Tan2011_40-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web">Tan, AJ. <a rel="nofollow" class="external text" href="http://emedicine.medscape.com/article/779218">"Hemolytic uremic syndrome in emergency medicine"</a>. <i>Medscape eMedicine</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Hemolytic+uremic+syndrome+in+emergency+medicine&amp;rft.aufirst=AJ&amp;rft.aulast=Tan&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Femedicine.medscape.com%2Farticle%2F779218&amp;rft.jtitle=Medscape+eMedicine&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Kanso2008-41"><span class="mw-cite-backlink">^ <a href="#cite_ref-Kanso2008_41-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Kanso2008_41-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Kanso, AA; Abou Hassan, NM; Badr, KF (2008). "Micro and macrovascular disease of the kidney". <i>In: Brenner BM, ed. the Kidney, 8th edition</i> (Philadelphia, PA: Saunders Elsevier): chapter 32.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Micro+and+macrovascular+disease+of+the+kidney&amp;rft.au=Abou+Hassan%2C+NM&amp;rft.au=Badr%2C+KF&amp;rft.aufirst=AA&amp;rft.aulast=Kanso&amp;rft.date=2008&amp;rft.genre=article&amp;rft.jtitle=In%3A+Brenner+BM%2C+ed.+the+Kidney%2C+8th+edition&amp;rft.pages=chapter+32&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Mead1998-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-Mead1998_42-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Mead, PS; Griffin, PM (1998). "Escherichia coli O157:H7". <i>Lancet</i> <b>352</b> (9135): 12071212. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0140-6736%2898%2901267-7">10.1016/S0140-6736(98)01267-7</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9777854">9777854</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Escherichia+coli+O157%3AH7&amp;rft.aufirst=PS&amp;rft.au=Griffin%2C+PM&amp;rft.aulast=Mead&amp;rft.date=1998&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2898%2901267-7&amp;rft_id=info%3Apmid%2F9777854&amp;rft.issue=9135&amp;rft.jtitle=Lancet&amp;rft.pages=1207-1212&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=352" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Ruggenenti2001-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-Ruggenenti2001_43-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Ruggenenti, P; Noris, M; Remuzzi, G (2001). "Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura". <i>Kidney Int</i> <b>60</b> (3): 831846. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1046%2Fj.1523-1755.2001.060003831.x">10.1046/j.1523-1755.2001.060003831.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11532079">11532079</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Thrombotic+microangiopathy%2C+hemolytic+uremic+syndrome%2C+and+thrombotic+thrombocytopenic+purpura&amp;rft.aufirst=P&amp;rft.aulast=Ruggenenti&amp;rft.au=Noris%2C+M&amp;rft.au=Remuzzi%2C+G&amp;rft.date=2001&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1046%2Fj.1523-1755.2001.060003831.x&amp;rft_id=info%3Apmid%2F11532079&amp;rft.issue=3&amp;rft.jtitle=Kidney+Int&amp;rft.pages=831-846&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=60" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-AlAkash2011-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-AlAkash2011_44-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Al-Akash, AI; Almond, PS; Savell, VH Jr; Gharaybeth, SI; Hogue, C (2011). "Eculizumab includes long-term remission in recurrent post-transpant HUS associated with C3 gene mutation". <i>Pediatr Nephrol</i> <b>26</b> (4): 613619. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2Fs00467-010-1708-6">10.1007/s00467-010-1708-6</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21125405">21125405</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Eculizumab+includes+long-term+remission+in+recurrent+post-transpant+HUS+associated+with+C3+gene+mutation&amp;rft.au=Almond%2C+PS&amp;rft.aufirst=AI&amp;rft.au=Gharaybeth%2C+SI&amp;rft.au=Hogue%2C+C&amp;rft.aulast=Al-Akash&amp;rft.au=Savell%2C+VH+Jr&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs00467-010-1708-6&amp;rft_id=info%3Apmid%2F21125405&amp;rft.issue=4&amp;rft.jtitle=Pediatr+Nephrol&amp;rft.pages=613-619&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=26" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Gagnadoux1996-45"><span class="mw-cite-backlink"><b><a href="#cite_ref-Gagnadoux1996_45-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Gangnadoux, MF; Habib, R; Gubler, MC; Bacri, JL; Broyer, M (1996). "Long-term (15-25 years) outcome of childhood hemolytic-uremic syndrome". <i>Clin Nephrol</i> <b>46</b> (1): 3941. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8832149">8832149</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Long-term+%2815-25+years%29+outcome+of+childhood+hemolytic-uremic+syndrome&amp;rft.au=Bacri%2C+JL&amp;rft.au=Broyer%2C+M&amp;rft.aufirst=MF&amp;rft.au=Gubler%2C+MC&amp;rft.au=Habib%2C+R&amp;rft.aulast=Gangnadoux&amp;rft.date=1996&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F8832149&amp;rft.issue=1&amp;rft.jtitle=Clin+Nephrol&amp;rft.pages=39-41&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=46" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Zheng2010-46"><span class="mw-cite-backlink"><b><a href="#cite_ref-Zheng2010_46-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Zhen,, XL; et al. (2010). "Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura". <i>Haematologica</i> <b>95</b> (9): 15551562. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.3324%2Fhaematol.2009.019299">10.3324/haematol.2009.019299</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>:&#160;2930958. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20378566">20378566</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Multiple+domains+of+ADAMTS13+are+targeted+by+autoantibodies+against+ADAMTS13+in+patients+with+acquired+idiopathic+thrombotic+thrombocytopenic+purpura&amp;rft.aufirst=XL&amp;rft.aulast=Zhen%2C&amp;rft.au=Shang%2C+D&amp;rft.au=Wu%2C+HM&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2930958&amp;rft_id=info%3Adoi%2F10.3324%2Fhaematol.2009.019299&amp;rft_id=info%3Apmid%2F20378566&amp;rft.issue=9&amp;rft.jtitle=Haematologica&amp;rft.pages=1555-1562&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=95" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid16918877-47"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid16918877_47-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid16918877_47-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation journal">Panos GZ, Betsi GI, Falagas ME (September 2006). <a rel="nofollow" class="external text" href="http://www.blackwell-synergy.com/openurl?genre=article&amp;sid=nlm:pubmed&amp;issn=0269-2813&amp;date=2006&amp;volume=24&amp;issue=5&amp;spage=731">"Systematic review: are antibiotics detrimental or beneficial for the treatment of patients with Escherichia coli O157:H7 infection?"</a>. <i>Aliment. Pharmacol. Ther.</i> <b>24</b> (5): 73142. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1365-2036.2006.03036.x">10.1111/j.1365-2036.2006.03036.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16918877">16918877</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Systematic+review%3A+are+antibiotics+detrimental+or+beneficial+for+the+treatment+of+patients+with+Escherichia+coli+O157%3AH7+infection%3F&amp;rft.au=Panos+GZ%2C+Betsi+GI%2C+Falagas+ME&amp;rft.date=2006-09&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.blackwell-synergy.com%2Fopenurl%3Fgenre%3Darticle%26sid%3Dnlm%3Apubmed%26issn%3D0269-2813%26date%3D2006%26volume%3D24%26issue%3D5%26spage%3D731&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1365-2036.2006.03036.x&amp;rft_id=info%3Apmid%2F16918877&amp;rft.issue=5&amp;rft.jtitle=Aliment.+Pharmacol.+Ther.&amp;rft.pages=731-42&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=24" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Multiple names: authors list (<a href="/wiki/Category:CS1_maint:_Multiple_names:_authors_list" title="Category:CS1 maint: Multiple names: authors list">link</a>)</span></span></li>
<li id="cite_note-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-48">^</a></b></span> <span class="reference-text"><cite class="citation journal">Gruppo RA, Rother RP (2009). <a rel="nofollow" class="external text" href="http://www.nejm.org/doi/full/10.1056/NEJMc0809959">"Eculizumab for congenital atypical hemolytic-uremic syndrome"</a>. <i><a href="/wiki/New_England_Journal_of_Medicine" title="New England Journal of Medicine" class="mw-redirect">N Engl J Med</a></i> <b>360</b> (5): 544546. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJMc0809959">10.1056/NEJMc0809959</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Eculizumab+for+congenital+atypical+hemolytic-uremic+syndrome&amp;rft.au=Gruppo+RA%2C+Rother+RP&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.nejm.org%2Fdoi%2Ffull%2F10.1056%2FNEJMc0809959&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMc0809959&amp;rft.issue=5&amp;rft.jtitle=N+Engl+J+Med&amp;rft.pages=544-546&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=360" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-49">^</a></b></span> <span class="reference-text"><cite class="citation journal">Lapeyraque, A-L; et al. (2011). <a rel="nofollow" class="external text" href="http://www.nejm.org/doi/full/10.1056/NEJMc1100859">"Eculizumab in Severe Shiga-ToxinAssociated HUS"</a>. <i><a href="/wiki/New_England_Journal_of_Medicine" title="New England Journal of Medicine" class="mw-redirect">N Engl J Med</a></i> <b>364</b> (26): 25612563. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJMc1100859">10.1056/NEJMc1100859</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21612462">21612462</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Eculizumab+in+Severe+Shiga-Toxin%93Associated+HUS&amp;rft.aufirst=A-L&amp;rft.aulast=Lapeyraque&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.nejm.org%2Fdoi%2Ffull%2F10.1056%2FNEJMc1100859&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMc1100859&amp;rft_id=info%3Apmid%2F21612462&amp;rft.issue=26&amp;rft.jtitle=N+Engl+J+Med&amp;rft.pages=2561-2563&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=364" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Parmar2010-50"><span class="mw-cite-backlink">^ <a href="#cite_ref-Parmar2010_50-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Parmar2010_50-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation web">Parmar, MS (2010). <a rel="nofollow" class="external text" href="http://emedicine.medscape.com/article/201181-overview#a0199">"Hemolytic-uremic syndrome"</a>. <i>Medscape eMedicine</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Hemolytic-uremic+syndrome&amp;rft.aufirst=MS&amp;rft.aulast=Parmar&amp;rft.date=2010&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Femedicine.medscape.com%2Farticle%2F201181-overview%23a0199&amp;rft.jtitle=Medscape+eMedicine&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Chu2004-51"><span class="mw-cite-backlink"><b><a href="#cite_ref-Chu2004_51-0">^</a></b></span> <span class="reference-text"><cite class="citation book">Chu, P; Hemphill, RR (2004). "222: Acquired hemolytic anemia". <i>Emergency Medicine: A Comprehensive Study Guide</i> (6th ed.). New York, NY: McGraw-Hill. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-07-138875-3" title="Special:BookSources/0-07-138875-3">0-07-138875-3</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=222%3A+Acquired+hemolytic+anemia&amp;rft.aufirst=P&amp;rft.au=Hemphill%2C+RR&amp;rft.aulast=Chu&amp;rft.btitle=Emergency+Medicine%3A+A+Comprehensive+Study+Guide&amp;rft.date=2004&amp;rft.edition=6th&amp;rft.genre=bookitem&amp;rft.isbn=0-07-138875-3&amp;rft.place=New+York%2C+NY&amp;rft.pub=McGraw-Hill&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid21492023-52"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid21492023_52-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Rivero, MA; Passucci, JA; Rodriguez, EM; Signorini, ML; Tarabla, HD; Parma, AE (2011). "Factors associated with sporadic verotoxigenic Escherichia coli infection in children with diarrhea from the Central Eastern Area of Argentina". <i>Foodborne pathogens and disease</i> <b>8</b> (8): 9016. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1089%2Ffpd.2010.0800">10.1089/fpd.2010.0800</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21492023">21492023</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Factors+associated+with+sporadic+verotoxigenic+Escherichia+coli+infection+in+children+with+diarrhea+from+the+Central+Eastern+Area+of+Argentina&amp;rft.aufirst=MA&amp;rft.aulast=Rivero&amp;rft.au=Parma%2C+AE&amp;rft.au=Passucci%2C+JA&amp;rft.au=Rodriguez%2C+EM&amp;rft.au=Signorini%2C+ML&amp;rft.au=Tarabla%2C+HD&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1089%2Ffpd.2010.0800&amp;rft_id=info%3Apmid%2F21492023&amp;rft.issue=8&amp;rft.jtitle=Foodborne+pathogens+and+disease&amp;rft.pages=901-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=8" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid14531383-53"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid14531383_53-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Rivas, M; Caletti, MG; Chinen, I; Refi, SM; Roldn, CD; Chillemi, G; Fiorilli, G; Bertolotti, A; Aguerre, L; Sosa Estani, S (2003). "Home-prepared hamburger and sporadic hemolytic uremic syndrome, Argentina". <i>Emerging Infectious Diseases</i> <b>9</b> (9): 11846. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.3201%2Feid0909.020563">10.3201/eid0909.020563</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>:&#160;3016759. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/14531383">14531383</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Home-prepared+hamburger+and+sporadic+hemolytic+uremic+syndrome%2C+Argentina&amp;rft.au=Aguerre%2C+L&amp;rft.au=Bertolotti%2C+A&amp;rft.au=Caletti%2C+MG&amp;rft.au=Chillemi%2C+G&amp;rft.au=Chinen%2C+I&amp;rft.au=Fiorilli%2C+G&amp;rft.aufirst=M&amp;rft.aulast=Rivas&amp;rft.au=Refi%2C+SM&amp;rft.au=Rold%C3%A1n%2C+CD&amp;rft.au=Sosa+Estani%2C+S&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3016759&amp;rft_id=info%3Adoi%2F10.3201%2Feid0909.020563&amp;rft_id=info%3Apmid%2F14531383&amp;rft.issue=9&amp;rft.jtitle=Emerging+Infectious+Diseases&amp;rft.pages=1184-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=9" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid15338982-54"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid15338982_54-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Rivero, MA; Padola, NL; Etcheverra, AI; Parma, AE (2004). "Enterohemorrhagic Escherichia coli and hemolytic-uremic syndrome in Argentina". <i>Medicina</i> <b>64</b> (4): 3526. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15338982">15338982</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Enterohemorrhagic+Escherichia+coli+and+hemolytic-uremic+syndrome+in+Argentina&amp;rft.au=Etcheverr%C3a%2C+AI&amp;rft.aufirst=MA&amp;rft.aulast=Rivero&amp;rft.au=Padola%2C+NL&amp;rft.au=Parma%2C+AE&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F15338982&amp;rft.issue=4&amp;rft.jtitle=Medicina&amp;rft.pages=352-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=64" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-55"><span class="mw-cite-backlink"><b><a href="#cite_ref-55">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.lusuh.org.ar/tripticoingles.pdf">"What is HUS?"</a> <span style="font-size:85%;">(PDF)</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.btitle=What+is+HUS%3F&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fwww.lusuh.org.ar%2Ftripticoingles.pdf&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Buchholz-56"><span class="mw-cite-backlink"><b><a href="#cite_ref-Buchholz_56-0">^</a></b></span> <span class="reference-text"><cite class="citation journal">Buchholz, U; et al. (2011). "German outbreak of escherichia coli O104:H4 associated with sprouts". <i>N Engl J Med</i> <b>365</b> (19): 17631770. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJMoa1106482">10.1056/NEJMoa1106482</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22029753">22029753</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=German+outbreak+of+escherichia+coli+O104%3AH4+associated+with+sprouts&amp;rft.au=Bernard%2C+H&amp;rft.aufirst=U&amp;rft.aulast=Buchholz&amp;rft.au=Werber%2C+D&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa1106482&amp;rft_id=info%3Apmid%2F22029753&amp;rft.issue=19&amp;rft.jtitle=N+Engl+J+Med&amp;rft.pages=1763-1770&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=365" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-57"><span class="mw-cite-backlink"><b><a href="#cite_ref-57">^</a></b></span> <span class="reference-text"><cite class="citation journal">Frank, C; et al. (2011). "Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany". <i>N Engl J Med</i> <b>365</b> (19): 17111780. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJMoa1106483">10.1056/NEJMoa1106483</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21696328">21696328</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.atitle=Epidemic+profile+of+Shiga-toxin-producing+Escherichia+coli+O104%3AH4+outbreak+in+Germany&amp;rft.au=Cramer%2C+JP&amp;rft.aufirst=C&amp;rft.aulast=Frank&amp;rft.au=Werber%2C+D&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa1106483&amp;rft_id=info%3Apmid%2F21696328&amp;rft.issue=19&amp;rft.jtitle=N+Engl+J+Med&amp;rft.pages=1711-1780&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=365" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Alexion-58"><span class="mw-cite-backlink"><b><a href="#cite_ref-Alexion_58-0">^</a></b></span> <span class="reference-text"><cite class="citation web">Alexion Pharmaceuticals Inc. (June 20, 2011). <a rel="nofollow" class="external text" href="http://news.alexionpharma.com/press-release/product-news/alexion-initiates-clinical-trial-eculizumab-potential-treatment-patients-">"Alexion initiates clinical trial of eculizumab as a potential treatment for patients with STEC-HUS in expanded response to EHEC crisis in Germany (press release)"</a>. Cheshire, CT.</cite><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHemolytic-uremic+syndrome&amp;rft.au=Alexion+Pharmaceuticals+Inc.&amp;rft.btitle=Alexion+initiates+clinical+trial+of+eculizumab+as+a+potential+treatment+for+patients+with+STEC-HUS+in+expanded+response+to+EHEC+crisis+in+Germany+%28press+release%29&amp;rft.date=2011-06-20&amp;rft.genre=unknown&amp;rft_id=http%3A%2F%2Fnews.alexionpharma.com%2Fpress-release%2Fproduct-news%2Falexion-initiates-clinical-trial-eculizumab-potential-treatment-patients-&amp;rft.place=Cheshire%2C+CT&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
</ol>
</div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hemolytic-uremic_syndrome&amp;action=edit&amp;section=10" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li><a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/books/NBK1367/">GeneReviews/NCBI/NIH/UW entry on Atypical hemolytic-uremic syndrome</a></li>
<li><a rel="nofollow" class="external text" href="http://www.ecoli-uk.com">Haemolytic Uraemic Syndrome Help (UK Based Charity for Information and Support)</a></li>
<li><a rel="nofollow" class="external text" href="http://ahusuk.org/">aHUS UK  A Patients and Families Support Group for atypical Haemolytic Uraemic Syndrome</a></li>
<li><a rel="nofollow" class="external text" href="http://www.clinimmsoc.org/teaching/slides/atypical_hus_and_complement_disorders.ppt">Atypical HUS and Complement Deficiencies - Clinical Immunology</a></li>
</ul>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks hlist collapsible collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Gram-negative_proteobacterial_diseases" title="Template:Gram-negative proteobacterial diseases"><abbr title="View this template" style=";;background:none transparent;border:none;">v</abbr></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Gram-negative_proteobacterial_diseases" title="Template talk:Gram-negative proteobacterial diseases"><abbr title="Discuss this template" style=";;background:none transparent;border:none;">t</abbr></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Gram-negative_proteobacterial_diseases&amp;action=edit"><abbr title="Edit this template" style=";;background:none transparent;border:none;">e</abbr></a></li>
</ul>
</div>
<div style="font-size:114%">
<ul>
<li><a href="/wiki/Infection" title="Infection">Infectious diseases</a></li>
<li><a href="/wiki/Pathogenic_bacteria" title="Pathogenic bacteria">Bacterial disease</a>: <a href="/wiki/Proteobacteria" title="Proteobacteria">Proteobacterial</a> <a href="/wiki/Gram-negative_bacterial_infection" title="Gram-negative bacterial infection">G</a>
<ul>
<li>primarily <a href="/wiki/ICD-10_Chapter_I:_Certain_infectious_and_parasitic_diseases#A00.E2.80.93A79_.E2.80.93_Bacterial_infections.2C_and_other_intestinal_infectious_diseases.2C_and_STDs" title="ICD-10 Chapter I: Certain infectious and parasitic diseases">A00A79</a>, <a href="/wiki/List_of_ICD-9_codes_001%E2%80%93139:_infectious_and_parasitic_diseases#1._Infectious_and_parasitic_diseases_.28001.E2.80.93139.29" title="List of ICD-9 codes 001139: infectious and parasitic diseases">001041, 080109</a></li>
</ul>
</li>
</ul>
</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Alphaproteobacteria" title="Alphaproteobacteria"></a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group" style="background-color: PowderBlue"><a href="/wiki/Rickettsiales" title="Rickettsiales">Rickettsiales</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group" style="background-color: PowderBlue"><a href="/wiki/Rickettsiaceae" title="Rickettsiaceae">Rickettsiaceae</a>/<br />
(<a href="/wiki/Rickettsiosis" title="Rickettsiosis">Rickettsioses</a>)</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group" style="background-color: PowderBlue"><a href="/wiki/Typhus" title="Typhus">Typhus</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Rickettsia_typhi" title="Rickettsia typhi">Rickettsia typhi</a></i>
<ul>
<li><a href="/wiki/Murine_typhus" title="Murine typhus">Murine typhus</a></li>
</ul>
</li>
<li><i><a href="/wiki/Rickettsia_prowazekii" title="Rickettsia prowazekii">Rickettsia prowazekii</a></i>
<ul>
<li><a href="/wiki/Epidemic_typhus" title="Epidemic typhus">Epidemic typhus</a>, <a href="/wiki/Brill%E2%80%93Zinsser_disease" title="BrillZinsser disease">BrillZinsser disease</a>, <a href="/wiki/Flying_squirrel_typhus" title="Flying squirrel typhus">Flying squirrel typhus</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: PowderBlue"><a href="/wiki/Spotted_fever" title="Spotted fever">Spotted<br />
fever</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group" style="background-color: PowderBlue"><a href="/wiki/Tick-borne_disease" title="Tick-borne disease">Tick-borne</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Rickettsia_rickettsii" title="Rickettsia rickettsii">Rickettsia rickettsii</a></i>
<ul>
<li><a href="/wiki/Rocky_Mountain_spotted_fever" title="Rocky Mountain spotted fever">Rocky Mountain spotted fever</a></li>
</ul>
</li>
<li><i><a href="/wiki/Rickettsia_conorii" title="Rickettsia conorii">Rickettsia conorii</a></i>
<ul>
<li><a href="/wiki/Boutonneuse_fever" title="Boutonneuse fever">Boutonneuse fever</a></li>
</ul>
</li>
<li><i><a href="/wiki/Rickettsia_japonica" title="Rickettsia japonica">Rickettsia japonica</a></i>
<ul>
<li><a href="/wiki/Japanese_spotted_fever" title="Japanese spotted fever">Japanese spotted fever</a></li>
</ul>
</li>
<li><i><a href="/wiki/Rickettsia_sibirica" title="Rickettsia sibirica">Rickettsia sibirica</a></i>
<ul>
<li><a href="/wiki/North_Asian_tick_typhus" title="North Asian tick typhus">North Asian tick typhus</a></li>
</ul>
</li>
<li><i><a href="/wiki/Rickettsia_australis" title="Rickettsia australis">Rickettsia australis</a></i>
<ul>
<li><a href="/wiki/Queensland_tick_typhus" title="Queensland tick typhus">Queensland tick typhus</a></li>
</ul>
</li>
<li><i><a href="/wiki/Rickettsia_honei" title="Rickettsia honei">Rickettsia honei</a></i>
<ul>
<li><a href="/wiki/Flinders_Island_spotted_fever" title="Flinders Island spotted fever">Flinders Island spotted fever</a></li>
</ul>
</li>
<li><i><a href="/wiki/Rickettsia_africae" title="Rickettsia africae">Rickettsia africae</a></i>
<ul>
<li><a href="/wiki/African_tick_bite_fever" title="African tick bite fever">African tick bite fever</a></li>
</ul>
</li>
<li><i><a href="/wiki/Rickettsia_parkeri" title="Rickettsia parkeri" class="mw-redirect">Rickettsia parkeri</a></i>
<ul>
<li><a href="/wiki/American_tick_bite_fever" title="American tick bite fever">American tick bite fever</a></li>
</ul>
</li>
<li><i><a href="/wiki/Rickettsia_aeschlimannii" title="Rickettsia aeschlimannii" class="mw-redirect">Rickettsia aeschlimannii</a></i>
<ul>
<li><a href="/wiki/Rickettsia_aeschlimannii_infection" title="Rickettsia aeschlimannii infection">Rickettsia aeschlimannii infection</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: PowderBlue"><a href="/wiki/Mite#Clinical_significance" title="Mite">Mite-borne</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Rickettsia_akari" title="Rickettsia akari">Rickettsia akari</a></i>
<ul>
<li><a href="/wiki/Rickettsialpox" title="Rickettsialpox">Rickettsialpox</a></li>
</ul>
</li>
<li><i><a href="/wiki/Orientia_tsutsugamushi" title="Orientia tsutsugamushi">Orientia tsutsugamushi</a></i>
<ul>
<li><a href="/wiki/Scrub_typhus" title="Scrub typhus">Scrub typhus</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: PowderBlue"><a href="/wiki/Flea#Fleas_as_a_vector" title="Flea">Flea-borne</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Rickettsia_felis" title="Rickettsia felis">Rickettsia felis</a></i>
<ul>
<li><a href="/wiki/Flea-borne_spotted_fever" title="Flea-borne spotted fever">Flea-borne spotted fever</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: PowderBlue"><a href="/wiki/Anaplasmataceae" title="Anaplasmataceae">Anaplasmataceae</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Ehrlichiosis" title="Ehrlichiosis">Ehrlichiosis</a>: <i><a href="/wiki/Anaplasma_phagocytophilum" title="Anaplasma phagocytophilum">Anaplasma phagocytophilum</a></i>
<ul>
<li><a href="/wiki/Human_granulocytic_anaplasmosis" title="Human granulocytic anaplasmosis">Human granulocytic anaplasmosis</a>, <a href="/wiki/Anaplasmosis" title="Anaplasmosis">Anaplasmosis</a></li>
</ul>
</li>
<li><i><a href="/wiki/Ehrlichia_chaffeensis" title="Ehrlichia chaffeensis">Ehrlichia chaffeensis</a></i>
<ul>
<li><a href="/wiki/Human_monocytotropic_ehrlichiosis" title="Human monocytotropic ehrlichiosis">Human monocytotropic ehrlichiosis</a></li>
</ul>
</li>
<li><i><a href="/wiki/Ehrlichia_ewingii" title="Ehrlichia ewingii">Ehrlichia ewingii</a></i>
<ul>
<li><a href="/wiki/Ehrlichiosis_ewingii_infection" title="Ehrlichiosis ewingii infection">Ehrlichiosis ewingii infection</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: PowderBlue"><a href="/wiki/Rhizobiales" title="Rhizobiales">Rhizobiales</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group" style="background-color: PowderBlue"><a href="/wiki/Brucellaceae" title="Brucellaceae">Brucellaceae</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Brucella" title="Brucella">Brucella abortus</a></i>
<ul>
<li><a href="/wiki/Brucellosis" title="Brucellosis">Brucellosis</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: PowderBlue"><a href="/wiki/Bartonellaceae" title="Bartonellaceae" class="mw-redirect">Bartonellaceae</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Bartonellosis" title="Bartonellosis">Bartonellosis</a>: <i><a href="/wiki/Bartonella_henselae" title="Bartonella henselae">Bartonella henselae</a></i>
<ul>
<li><a href="/wiki/Cat-scratch_disease" title="Cat-scratch disease">Cat-scratch disease</a></li>
</ul>
</li>
<li><i><a href="/wiki/Bartonella_quintana" title="Bartonella quintana">Bartonella quintana</a></i>
<ul>
<li><a href="/wiki/Trench_fever" title="Trench fever">Trench fever</a></li>
</ul>
</li>
<li><i>either henselae or quintana</i>
<ul>
<li><a href="/wiki/Bacillary_angiomatosis" title="Bacillary angiomatosis">Bacillary angiomatosis</a></li>
</ul>
</li>
<li><i><a href="/wiki/Bartonella_bacilliformis" title="Bartonella bacilliformis">Bartonella bacilliformis</a></i>
<ul>
<li><a href="/wiki/Carrion%27s_disease" title="Carrion's disease">Carrion's disease</a>, <a href="/wiki/Verruga_peruana" title="Verruga peruana">Verruga peruana</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Betaproteobacteria" title="Betaproteobacteria"></a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group" style="background-color: PowderBlue"><a href="/wiki/Neisseriaceae" title="Neisseriaceae">Neisseriales</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group" style="background-color: PowderBlue"><a href="/wiki/Maltose" title="Maltose">M+</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Neisseria_meningitidis" title="Neisseria meningitidis">Neisseria meningitidis/meningococcus</a></i>
<ul>
<li><a href="/wiki/Meningococcal_disease" title="Meningococcal disease">Meningococcal disease</a>, <a href="/wiki/Waterhouse%E2%80%93Friderichsen_syndrome" title="WaterhouseFriderichsen syndrome">WaterhouseFriderichsen syndrome</a>, <a href="/wiki/Meningococcal_septicaemia" title="Meningococcal septicaemia" class="mw-redirect">Meningococcal septicaemia</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: PowderBlue"><a href="/wiki/Maltose" title="Maltose">M-</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Neisseria_gonorrhoeae" title="Neisseria gonorrhoeae">Neisseria gonorrhoeae/gonococcus</a></i>
<ul>
<li><a href="/wiki/Gonorrhea" title="Gonorrhea">Gonorrhea</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: PowderBlue"><span style="font-weight:normal;"><i>ungrouped:</i></span></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Eikenella_corrodens" title="Eikenella corrodens">Eikenella corrodens</a></i>/<i><a href="/wiki/Kingella_kingae" title="Kingella kingae">Kingella kingae</a></i>
<ul>
<li><a href="/wiki/HACEK_endocarditis" title="HACEK endocarditis">HACEK</a></li>
</ul>
</li>
<li><i><a href="/wiki/Chromobacterium_violaceum" title="Chromobacterium violaceum">Chromobacterium violaceum</a></i>
<ul>
<li><a href="/wiki/Chromobacteriosis_infection" title="Chromobacteriosis infection">Chromobacteriosis infection</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: PowderBlue"><a href="/wiki/Burkholderiales" title="Burkholderiales">Burkholderiales</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Burkholderia_pseudomallei" title="Burkholderia pseudomallei">Burkholderia pseudomallei</a></i>
<ul>
<li><a href="/wiki/Melioidosis" title="Melioidosis">Melioidosis</a></li>
</ul>
</li>
<li><i><a href="/wiki/Burkholderia_mallei" title="Burkholderia mallei">Burkholderia mallei</a></i>
<ul>
<li><a href="/wiki/Glanders" title="Glanders">Glanders</a></li>
</ul>
</li>
<li><i><a href="/wiki/Burkholderia_cepacia_complex" title="Burkholderia cepacia complex">Burkholderia cepacia complex</a></i></li>
<li><i><a href="/wiki/Bordetella_pertussis" title="Bordetella pertussis">Bordetella pertussis</a>/<a href="/wiki/Bordetella_parapertussis" title="Bordetella parapertussis">Bordetella parapertussis</a></i>
<ul>
<li><a href="/wiki/Pertussis" title="Pertussis">Pertussis</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Gammaproteobacteria" title="Gammaproteobacteria"></a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group" style="background-color: PowderBlue"><a href="/wiki/Enterobacteriaceae" title="Enterobacteriaceae">Enterobacteriales</a><br />
(<a href="/wiki/Oxidase_test#OX-" title="Oxidase test">OX-</a>)</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group" style="background-color: PowderBlue"><a href="/wiki/MacConkey_agar#Lac.2B" title="MacConkey agar">Lac+</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Klebsiella_pneumoniae" title="Klebsiella pneumoniae">Klebsiella pneumoniae</a></i>
<ul>
<li><a href="/wiki/Rhinoscleroma" title="Rhinoscleroma">Rhinoscleroma</a>, <a href="/wiki/Klebsiella_pneumonia" title="Klebsiella pneumonia">Klebsiella pneumonia</a></li>
</ul>
</li>
<li><i><a href="/wiki/Klebsiella_granulomatis" title="Klebsiella granulomatis">Klebsiella granulomatis</a></i>
<ul>
<li><a href="/wiki/Granuloma_inguinale" title="Granuloma inguinale">Granuloma inguinale</a></li>
</ul>
</li>
<li><i><a href="/wiki/Klebsiella_oxytoca" title="Klebsiella oxytoca">Klebsiella oxytoca</a></i></li>
</ul>
<ul>
<li><i><a href="/wiki/Escherichia_coli" title="Escherichia coli">Escherichia coli</a></i>: <a href="/wiki/Enterotoxigenic_Escherichia_coli" title="Enterotoxigenic Escherichia coli">Enterotoxigenic</a></li>
<li><a href="/wiki/Enteroinvasive_Escherichia_coli" title="Enteroinvasive Escherichia coli">Enteroinvasive</a></li>
<li><a href="/wiki/Verotoxin-producing_Escherichia_coli" title="Verotoxin-producing Escherichia coli">Enterohemorrhagic</a></li>
<li><a href="/wiki/Escherichia_coli_O157:H7" title="Escherichia coli O157:H7">O157:H7</a></li>
<li><a href="/wiki/Escherichia_coli_O104:H4" title="Escherichia coli O104:H4">O104:H4</a>
<ul>
<li><strong class="selflink">Hemolytic-uremic syndrome</strong></li>
</ul>
</li>
</ul>
<ul>
<li><i><a href="/wiki/Enterobacter_aerogenes" title="Enterobacter aerogenes">Enterobacter aerogenes</a>/<a href="/wiki/Enterobacter_cloacae" title="Enterobacter cloacae">Enterobacter cloacae</a></i></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: PowderBlue"><a href="/wiki/MacConkey_agar#Slow" title="MacConkey agar">Slow/weak</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Serratia_marcescens" title="Serratia marcescens">Serratia marcescens</a></i>
<ul>
<li><a href="/wiki/Serratia_infection" title="Serratia infection">Serratia infection</a></li>
</ul>
</li>
<li><i><a href="/wiki/Citrobacter_koseri" title="Citrobacter koseri">Citrobacter koseri</a></i>/<i><a href="/wiki/Citrobacter_freundii" title="Citrobacter freundii">Citrobacter freundii</a></i></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: PowderBlue"><a href="/wiki/MacConkey_agar#Lac-" title="MacConkey agar">Lac-</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group" style="background-color: PowderBlue"><a href="/wiki/Bismuth_sulfite_agar" title="Bismuth sulfite agar">H2S+</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Salmonella_enterica" title="Salmonella enterica">Salmonella enterica</a></i>
<ul>
<li><a href="/wiki/Typhoid_fever" title="Typhoid fever">Typhoid fever</a>, <a href="/wiki/Paratyphoid_fever" title="Paratyphoid fever">Paratyphoid fever</a>, <a href="/wiki/Salmonellosis" title="Salmonellosis">Salmonellosis</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: PowderBlue">H2S-</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Shigella_dysenteriae" title="Shigella dysenteriae">Shigella dysenteriae</a>/<a href="/wiki/Shigella_sonnei" title="Shigella sonnei">sonnei</a>/<a href="/wiki/Shigella_flexneri" title="Shigella flexneri">flexneri</a>/<a href="/wiki/Shigella_boydii" title="Shigella boydii">boydii</a></i>
<ul>
<li><a href="/wiki/Shigellosis" title="Shigellosis">Shigellosis</a>, <a href="/wiki/Bacillary_dysentery" title="Bacillary dysentery">Bacillary dysentery</a></li>
</ul>
</li>
<li><i><a href="/wiki/Proteus_mirabilis" title="Proteus mirabilis">Proteus mirabilis</a></i>/<i><a href="/wiki/Proteus_vulgaris" title="Proteus vulgaris">Proteus vulgaris</a></i></li>
<li><i><a href="/wiki/Yersinia_pestis" title="Yersinia pestis">Yersinia pestis</a></i>
<ul>
<li><a href="/wiki/Plague_(disease)" title="Plague (disease)">Plague</a>/<a href="/wiki/Bubonic_plague" title="Bubonic plague">Bubonic plague</a></li>
</ul>
</li>
<li><i><a href="/wiki/Yersinia_enterocolitica" title="Yersinia enterocolitica">Yersinia enterocolitica</a></i>
<ul>
<li><a href="/wiki/Yersiniosis" title="Yersiniosis">Yersiniosis</a></li>
</ul>
</li>
<li><i><a href="/wiki/Yersinia_pseudotuberculosis" title="Yersinia pseudotuberculosis">Yersinia pseudotuberculosis</a></i>
<ul>
<li><a href="/wiki/Far_East_scarlet-like_fever" title="Far East scarlet-like fever">Far East scarlet-like fever</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: PowderBlue"><a href="/wiki/Pasteurellaceae" title="Pasteurellaceae">Pasteurellales</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group" style="background-color: PowderBlue"><span style="font-weight:normal;"><i><a href="/wiki/Haemophilus" title="Haemophilus">Haemophilus</a>:</i></span></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Haemophilus_influenzae" title="Haemophilus influenzae">H. influenzae</a></i>
<ul>
<li><a href="/wiki/Haemophilus_meningitis" title="Haemophilus meningitis">Haemophilus meningitis</a></li>
<li><a href="/wiki/Brazilian_purpuric_fever" title="Brazilian purpuric fever">Brazilian purpuric fever</a></li>
</ul>
</li>
<li><i><a href="/wiki/Haemophilus_ducreyi" title="Haemophilus ducreyi">H. ducreyi</a></i>
<ul>
<li><a href="/wiki/Chancroid" title="Chancroid">Chancroid</a></li>
</ul>
</li>
<li><i><a href="/wiki/Haemophilus_parainfluenzae" title="Haemophilus parainfluenzae">H. parainfluenzae</a></i>
<ul>
<li><a href="/wiki/HACEK_endocarditis" title="HACEK endocarditis">HACEK</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: PowderBlue"><span style="font-weight:normal;"><i><a href="/wiki/Pasteurella_multocida" title="Pasteurella multocida">Pasteurella multocida</a></i></span></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Pasteurellosis" title="Pasteurellosis">Pasteurellosis</a></li>
<li><i><a href="/wiki/Actinobacillus" title="Actinobacillus">Actinobacillus</a></i>
<ul>
<li><a href="/wiki/Actinobacillosis" title="Actinobacillosis">Actinobacillosis</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: PowderBlue"><span style="font-weight:normal;"><i><a href="/wiki/Aggregatibacter_actinomycetemcomitans" title="Aggregatibacter actinomycetemcomitans">Aggregatibacter actinomycetemcomitans</a></i></span></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/HACEK_endocarditis" title="HACEK endocarditis">HACEK</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: PowderBlue"><a href="/wiki/Legionellales" title="Legionellales">Legionellales</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Legionella_pneumophila" title="Legionella pneumophila">Legionella pneumophila</a>/<a href="/wiki/Legionella_longbeachae" title="Legionella longbeachae">Legionella longbeachae</a></i>
<ul>
<li><a href="/wiki/Legionnaires%27_disease" title="Legionnaires' disease">Legionnaires' disease</a></li>
</ul>
</li>
<li><i><a href="/wiki/Coxiella_burnetii" title="Coxiella burnetii">Coxiella burnetii</a></i>
<ul>
<li><a href="/wiki/Q_fever" title="Q fever">Q fever</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: PowderBlue"><a href="/wiki/Thiotrichales" title="Thiotrichales">Thiotrichales</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Francisella_tularensis" title="Francisella tularensis">Francisella tularensis</a></i>
<ul>
<li><a href="/wiki/Tularemia" title="Tularemia">Tularemia</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: PowderBlue"><a href="/wiki/Vibrionaceae" title="Vibrionaceae">Vibrionaceae</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Vibrio_cholerae" title="Vibrio cholerae">Vibrio cholerae</a></i>
<ul>
<li><a href="/wiki/Cholera" title="Cholera">Cholera</a></li>
</ul>
</li>
<li><i><a href="/wiki/Vibrio_vulnificus" title="Vibrio vulnificus">Vibrio vulnificus</a></i></li>
<li><i><a href="/wiki/Vibrio_parahaemolyticus" title="Vibrio parahaemolyticus">Vibrio parahaemolyticus</a></i></li>
<li><i><a href="/wiki/Vibrio_alginolyticus" title="Vibrio alginolyticus">Vibrio alginolyticus</a></i></li>
<li><i><a href="/wiki/Plesiomonas_shigelloides" title="Plesiomonas shigelloides">Plesiomonas shigelloides</a></i></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: PowderBlue"><a href="/wiki/Pseudomonadales" title="Pseudomonadales">Pseudomonadales</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Pseudomonas_aeruginosa" title="Pseudomonas aeruginosa">Pseudomonas aeruginosa</a></i>
<ul>
<li><a href="/wiki/Pseudomonas_infection" title="Pseudomonas infection">Pseudomonas infection</a></li>
</ul>
</li>
<li><i><a href="/wiki/Moraxella_catarrhalis" title="Moraxella catarrhalis">Moraxella catarrhalis</a></i></li>
<li><i><a href="/wiki/Acinetobacter_baumannii" title="Acinetobacter baumannii">Acinetobacter baumannii</a></i></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: PowderBlue"><a href="/wiki/Xanthomonadaceae" title="Xanthomonadaceae">Xanthomonadaceae</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Stenotrophomonas_maltophilia" title="Stenotrophomonas maltophilia">Stenotrophomonas maltophilia</a></i></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: PowderBlue"><a href="/wiki/Cardiobacteriaceae" title="Cardiobacteriaceae">Cardiobacteriaceae</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Cardiobacterium_hominis" title="Cardiobacterium hominis">Cardiobacterium hominis</a></i>
<ul>
<li><a href="/wiki/HACEK_endocarditis" title="HACEK endocarditis">HACEK</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background-color: PowderBlue"><a href="/wiki/Aeromonadales" title="Aeromonadales">Aeromonadales</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Aeromonas_hydrophila" title="Aeromonas hydrophila">Aeromonas hydrophila</a>/<a href="/wiki/Aeromonas_veronii" title="Aeromonas veronii">Aeromonas veronii</a></i>
<ul>
<li><a href="/wiki/Aeromonas_infection" title="Aeromonas infection">Aeromonas infection</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Epsilonproteobacteria" title="Epsilonproteobacteria"></a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group" style="background-color: PowderBlue"><a href="/wiki/Campylobacterales" title="Campylobacterales">Campylobacterales</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Campylobacter_jejuni" title="Campylobacter jejuni">Campylobacter jejuni</a></i>
<ul>
<li><a href="/wiki/Campylobacteriosis" title="Campylobacteriosis">Campylobacteriosis</a>, <a href="/wiki/Guillain%E2%80%93Barr%C3%A9_syndrome" title="GuillainBarr syndrome">GuillainBarr syndrome</a></li>
</ul>
</li>
<li><i><a href="/wiki/Helicobacter_pylori" title="Helicobacter pylori">Helicobacter pylori</a></i>
<ul>
<li><a href="/wiki/Peptic_ulcer" title="Peptic ulcer">Peptic ulcer</a>, <a href="/wiki/MALT_lymphoma" title="MALT lymphoma">MALT lymphoma</a>, <a href="/wiki/Gastric_cancer" title="Gastric cancer" class="mw-redirect">Gastric cancer</a></li>
</ul>
</li>
<li><i><a href="/wiki/Helicobacter_cinaedi" title="Helicobacter cinaedi">Helicobacter cinaedi</a></i>
<ul>
<li><a href="/wiki/Helicobacter_cellulitis" title="Helicobacter cellulitis">Helicobacter cellulitis</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Diseases_of_RBCs" title="Template:Diseases of RBCs"><abbr title="View this template" style=";;background:none transparent;border:none;">v</abbr></a></li>
<li class="nv-talk"><a href="/w/index.php?title=Template_talk:Diseases_of_RBCs&amp;action=edit&amp;redlink=1" class="new" title="Template talk:Diseases of RBCs (page does not exist)"><abbr title="Discuss this template" style=";;background:none transparent;border:none;">t</abbr></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Diseases_of_RBCs&amp;action=edit"><abbr title="Edit this template" style=";;background:none transparent;border:none;">e</abbr></a></li>
</ul>
</div>
<div style="font-size:114%"><a href="/wiki/Hematologic_disease" title="Hematologic disease">Diseases</a> of <a href="/wiki/Red_blood_cell" title="Red blood cell">red blood cells</a> (<a href="/wiki/ICD-10_Chapter_III:_Diseases_of_the_blood_and_blood-forming_organs,_and_certain_disorders_involving_the_immune_mechanism#D50-D89_-_Diseases_of_the_blood_and_blood-forming_organs_and_certain_disorders_involving_the_immune_mechanism" title="ICD-10 Chapter III: Diseases of the blood and blood-forming organs, and certain disorders involving the immune mechanism">D5069,74</a>, <a href="/wiki/List_of_ICD-9_codes_280%E2%80%93289:_diseases_of_the_blood_and_blood-forming_organs" title="List of ICD-9 codes 280289: diseases of the blood and blood-forming organs">280287</a>)</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Red_blood_cell" title="Red blood cell">Red<br />
blood cells</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Polycythemia" title="Polycythemia">Polycythemia</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Polycythemia_vera" title="Polycythemia vera">Polycythemia vera</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Anemia" title="Anemia">Anemia</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Nutritional_anemia" title="Nutritional anemia">Nutritional</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Microcytic_anemia" title="Microcytic anemia">Micro-</a>: <a href="/wiki/Iron-deficiency_anemia" title="Iron-deficiency anemia">Iron-deficiency anemia</a>
<ul>
<li><a href="/wiki/Plummer%E2%80%93Vinson_syndrome" title="PlummerVinson syndrome">PlummerVinson syndrome</a></li>
</ul>
</li>
</ul>
<ul>
<li><a href="/wiki/Macrocytic_anemia" title="Macrocytic anemia">Macro-</a>: <a href="/wiki/Megaloblastic_anemia" title="Megaloblastic anemia">Megaloblastic anemia</a>
<ul>
<li><a href="/wiki/Pernicious_anemia" title="Pernicious anemia">Pernicious anemia</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Hemolytic_anemia" title="Hemolytic anemia">Hemolytic</a><br />
(mostly <a href="/wiki/Normocytic_anemia" title="Normocytic anemia">normo-</a>)</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Congenital_hemolytic_anemia" title="Congenital hemolytic anemia">Hereditary</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Enzymopathy" title="Enzymopathy" class="mw-redirect">enzymopathy</a>:</i> <a href="/wiki/Glucose-6-phosphate_dehydrogenase_deficiency" title="Glucose-6-phosphate dehydrogenase deficiency">G6PD</a></li>
<li><i><a href="/wiki/Glycolysis" title="Glycolysis">glycolysis</a></i>
<ul>
<li><a href="/wiki/Pyruvate_kinase_deficiency" title="Pyruvate kinase deficiency">PK</a></li>
<li><a href="/wiki/Triosephosphate_isomerase_deficiency" title="Triosephosphate isomerase deficiency">TI</a></li>
<li><a href="/wiki/Hexokinase_deficiency" title="Hexokinase deficiency">HK</a></li>
</ul>
</li>
</ul>
<ul>
<li><i><a href="/wiki/Hemoglobinopathy" title="Hemoglobinopathy">hemoglobinopathy</a>:</i> <a href="/wiki/Thalassemia" title="Thalassemia">Thalassemia</a>
<ul>
<li><a href="/wiki/Alpha-thalassemia" title="Alpha-thalassemia">alpha</a></li>
<li><a href="/wiki/Beta-thalassemia" title="Beta-thalassemia" class="mw-redirect">beta</a></li>
<li><a href="/wiki/Delta-thalassemia" title="Delta-thalassemia">delta</a></li>
</ul>
</li>
<li><a href="/wiki/Sickle-cell_disease" title="Sickle-cell disease">Sickle-cell disease</a>/<a href="/wiki/Sickle_cell_trait" title="Sickle cell trait">trait</a></li>
<li><a href="/wiki/Hereditary_persistence_of_fetal_hemoglobin" title="Hereditary persistence of fetal hemoglobin">HPFH</a></li>
</ul>
<ul>
<li><i><a href="/wiki/Red_blood_cell#Membranes_and_surface_proteins" title="Red blood cell">membrane</a>:</i> <a href="/wiki/Hereditary_spherocytosis" title="Hereditary spherocytosis">Hereditary spherocytosis</a>
<ul>
<li><a href="/wiki/Minkowski%E2%80%93Chauffard_syndrome" title="MinkowskiChauffard syndrome" class="mw-redirect">MinkowskiChauffard syndrome</a></li>
</ul>
</li>
<li><a href="/wiki/Hereditary_elliptocytosis" title="Hereditary elliptocytosis">Hereditary elliptocytosis</a>
<ul>
<li><a href="/wiki/Southeast_Asian_ovalocytosis" title="Southeast Asian ovalocytosis">Southeast Asian ovalocytosis</a></li>
</ul>
</li>
<li><a href="/wiki/Hereditary_stomatocytosis" title="Hereditary stomatocytosis">Hereditary stomatocytosis</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Acquired_hemolytic_anemia" title="Acquired hemolytic anemia">Acquired</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Autoimmune_hemolytic_anemia" title="Autoimmune hemolytic anemia">Autoimmune</a>
<ul>
<li><a href="/wiki/Warm_autoimmune_hemolytic_anemia" title="Warm autoimmune hemolytic anemia">WAHA</a></li>
<li><a href="/wiki/Cold_agglutinin_disease" title="Cold agglutinin disease">CAD</a></li>
<li><a href="/wiki/Paroxysmal_cold_hemoglobinuria" title="Paroxysmal cold hemoglobinuria">PCH</a></li>
</ul>
</li>
</ul>
<ul>
<li><i><a href="/wiki/Red_blood_cell#Membranes_and_surface_proteins" title="Red blood cell">membrane</a></i>
<ul>
<li><a href="/wiki/Paroxysmal_nocturnal_hemoglobinuria" title="Paroxysmal nocturnal hemoglobinuria">PNH</a></li>
</ul>
</li>
</ul>
<ul>
<li><a href="/wiki/Microangiopathic_hemolytic_anemia" title="Microangiopathic hemolytic anemia">MAHA</a></li>
<li><a href="/wiki/Thrombotic_microangiopathy" title="Thrombotic microangiopathy">TM</a>
<ul>
<li><strong class="selflink">HUS</strong></li>
</ul>
</li>
</ul>
<ul>
<li><a href="/wiki/Drug-induced_autoimmune_hemolytic_anemia" title="Drug-induced autoimmune hemolytic anemia">Drug-induced autoimmune</a></li>
<li><a href="/wiki/Drug-induced_nonautoimmune_hemolytic_anemia" title="Drug-induced nonautoimmune hemolytic anemia">Drug-induced nonautoimmune</a></li>
</ul>
<ul>
<li><a href="/wiki/Hemolytic_disease_of_the_newborn" title="Hemolytic disease of the newborn">Hemolytic disease of the newborn</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Aplastic_anemia" title="Aplastic anemia">Aplastic</a><br />
(mostly <a href="/wiki/Normocytic_anemia" title="Normocytic anemia">normo-</a>)</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Congenital_hypoplastic_anemia" title="Congenital hypoplastic anemia">Hereditary</a>: <a href="/wiki/Fanconi_anemia" title="Fanconi anemia">Fanconi anemia</a></li>
<li><a href="/wiki/Diamond%E2%80%93Blackfan_anemia" title="DiamondBlackfan anemia">DiamondBlackfan anemia</a></li>
</ul>
<ul>
<li>Acquired: <a href="/wiki/Pure_red_cell_aplasia" title="Pure red cell aplasia">PRCA</a></li>
<li><a href="/wiki/Sideroblastic_anemia" title="Sideroblastic anemia">Sideroblastic anemia</a></li>
<li><a href="/wiki/Myelophthisic_anemia" title="Myelophthisic anemia">Myelophthisic</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Red_blood_cell_indices" title="Red blood cell indices">Blood tests</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Mean_corpuscular_volume" title="Mean corpuscular volume">MCV</a></i>
<ul>
<li><a href="/wiki/Normocytic_anemia" title="Normocytic anemia">Normocytic</a></li>
<li><a href="/wiki/Microcytic_anemia" title="Microcytic anemia">Microcytic</a></li>
<li><a href="/wiki/Macrocytic_anemia" title="Macrocytic anemia">Macrocytic</a></li>
</ul>
</li>
<li><i><a href="/wiki/Mean_corpuscular_hemoglobin_concentration" title="Mean corpuscular hemoglobin concentration">MCHC</a></i>
<ul>
<li><a href="/wiki/Normochromic_anemia" title="Normochromic anemia">Normochromic</a></li>
<li><a href="/wiki/Hypochromic_anemia" title="Hypochromic anemia">Hypochromic</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Other</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Methemoglobinemia" title="Methemoglobinemia">Methemoglobinemia</a></li>
<li><a href="/wiki/Sulfhemoglobinemia" title="Sulfhemoglobinemia">Sulfhemoglobinemia</a></li>
<li><a href="/wiki/Reticulocytopenia" title="Reticulocytopenia">Reticulocytopenia</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Parsed by mw1252
Cached time: 20160421193341
Cache expiry: 86400
Dynamic content: true
CPU time usage: 0.644 seconds
Real time usage: 0.699 seconds
Preprocessor visited node count: 4601/1000000
Preprocessor generated node count: 0/1500000
Postexpand include size: 296689/2097152 bytes
Template argument size: 552/2097152 bytes
Highest expansion depth: 11/40
Expensive parser function count: 0/500
Lua time usage: 0.328/10.000 seconds
Lua memory usage: 4.4 MB/50 MB
Number of Wikibase entities loaded: 1-->

<!-- 
Transclusion expansion time report (%,ms,calls,template)
100.00%  593.469      1 - -total
 61.70%  366.173      1 - Template:Reflist
 41.62%  246.984     48 - Template:Cite_journal
 28.75%  170.619     19 - Template:Navbox
 13.09%   77.703      1 - Template:Infobox_medical_condition
 11.97%   71.050      1 - Template:Infobox
  9.14%   54.252      1 - Template:Gram-negative_proteobacterial_bacterial_diseases
  3.73%   22.131      6 - Template:Cite_web
  3.22%   19.133      1 - Template:Diseases_of_RBCs
  2.03%   12.050      3 - Template:Cite_book
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:542776-0!*!0!!en!4!* and timestamp 20160421193340 and revision id 711338223
 -->
<noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>					<div class="printfooter">
						Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Hemolytic-uremic_syndrome&amp;oldid=711338223">https://en.wikipedia.org/w/index.php?title=Hemolytic-uremic_syndrome&amp;oldid=711338223</a>"					</div>
				<div id="catlinks" class="catlinks" data-mw="interface"><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Nephrology" title="Category:Nephrology">Nephrology</a></li><li><a href="/wiki/Category:Syndromes" title="Category:Syndromes">Syndromes</a></li><li><a href="/wiki/Category:Acquired_hemolytic_anemia" title="Category:Acquired hemolytic anemia">Acquired hemolytic anemia</a></li><li><a href="/wiki/Category:Blood_disorders" title="Category:Blood disorders">Blood disorders</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:CS1_maint:_Multiple_names:_authors_list" title="Category:CS1 maint: Multiple names: authors list">CS1 maint: Multiple names: authors list</a></li><li><a href="/wiki/Category:CS1_German-language_sources_(de)" title="Category:CS1 German-language sources (de)">CS1 German-language sources (de)</a></li><li><a href="/wiki/Category:Articles_with_contributors_link" title="Category:Articles with contributors link">Articles with contributors link</a></li></ul></div></div>				<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>

			<div id="mw-head">
									<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
						<h3 id="p-personal-label">Personal tools</h3>
						<ul>
							<li id="pt-anonuserpage">Not logged in</li><li id="pt-anontalk"><a href="/wiki/Special:MyTalk" title="Discussion about edits from this IP address [n]" accesskey="n">Talk</a></li><li id="pt-anoncontribs"><a href="/wiki/Special:MyContributions" title="A list of edits made from this IP address [y]" accesskey="y">Contributions</a></li><li id="pt-createaccount"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Hemolytic-uremic+syndrome&amp;type=signup" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Hemolytic-uremic+syndrome" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o">Log in</a></li>						</ul>
					</div>
									<div id="left-navigation">
										<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
						<h3 id="p-namespaces-label">Namespaces</h3>
						<ul>
															<li  id="ca-nstab-main" class="selected"><span><a href="/wiki/Hemolytic-uremic_syndrome"  title="View the content page [c]" accesskey="c">Article</a></span></li>
															<li  id="ca-talk"><span><a href="/wiki/Talk:Hemolytic-uremic_syndrome"  title="Discussion about the content page [t]" accesskey="t" rel="discussion">Talk</a></span></li>
													</ul>
					</div>
										<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
												<h3 id="p-variants-label">
							<span>Variants</span><a href="#"></a>
						</h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
									</div>
				<div id="right-navigation">
										<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
						<h3 id="p-views-label">Views</h3>
						<ul>
															<li id="ca-view" class="selected"><span><a href="/wiki/Hemolytic-uremic_syndrome" >Read</a></span></li>
															<li id="ca-edit"><span><a href="/w/index.php?title=Hemolytic-uremic_syndrome&amp;action=edit"  title="Edit this page [e]" accesskey="e">Edit</a></span></li>
															<li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=Hemolytic-uremic_syndrome&amp;action=history"  title="Past revisions of this page [h]" accesskey="h">View history</a></span></li>
													</ul>
					</div>
										<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
						<h3 id="p-cactions-label"><span>More</span><a href="#"></a></h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
										<div id="p-search" role="search">
						<h3>
							<label for="searchInput">Search</label>
						</h3>

						<form action="/w/index.php" id="searchform">
							<div id="simpleSearch">
							<input type="search" name="search" placeholder="Search" title="Search Wikipedia [f]" accesskey="f" id="searchInput"/><input type="hidden" value="Special:Search" name="title"/><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton"/><input type="submit" name="go" value="Go" title="Go to a page with this exact name if it exists" id="searchButton" class="searchButton"/>							</div>
						</form>
					</div>
									</div>
			</div>
			<div id="mw-panel">
				<div id="p-logo" role="banner"><a class="mw-wiki-logo" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
						<div class="portal" role="navigation" id='p-navigation' aria-labelledby='p-navigation-label'>
			<h3 id='p-navigation-label'>Navigation</h3>

			<div class="body">
									<ul>
						<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li><li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content  the best of Wikipedia">Featured content</a></li><li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li><li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li><li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li><li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikipedia store">Wikipedia store</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-interaction' aria-labelledby='p-interaction-label'>
			<h3 id='p-interaction-label'>Interaction</h3>

			<div class="body">
									<ul>
						<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li><li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li><li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li><li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia">Contact page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-tb' aria-labelledby='p-tb-label'>
			<h3 id='p-tb-label'>Tools</h3>

			<div class="body">
									<ul>
						<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Hemolytic-uremic_syndrome" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li><li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Hemolytic-uremic_syndrome" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li><li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li><li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li><li id="t-permalink"><a href="/w/index.php?title=Hemolytic-uremic_syndrome&amp;oldid=711338223" title="Permanent link to this revision of the page">Permanent link</a></li><li id="t-info"><a href="/w/index.php?title=Hemolytic-uremic_syndrome&amp;action=info" title="More information about this page">Page information</a></li><li id="t-wikibase"><a href="//www.wikidata.org/wiki/Q162266" title="Link to connected data repository item [g]" accesskey="g">Wikidata item</a></li><li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Hemolytic-uremic_syndrome&amp;id=711338223" title="Information on how to cite this page">Cite this page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-coll-print_export' aria-labelledby='p-coll-print_export-label'>
			<h3 id='p-coll-print_export-label'>Print/export</h3>

			<div class="body">
									<ul>
						<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Hemolytic-uremic+syndrome">Create a book</a></li><li id="coll-download-as-rdf2latex"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Hemolytic-uremic+syndrome&amp;returnto=Hemolytic-uremic+syndrome&amp;oldid=711338223&amp;writer=rdf2latex">Download as PDF</a></li><li id="t-print"><a href="/w/index.php?title=Hemolytic-uremic_syndrome&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-lang' aria-labelledby='p-lang-label'>
			<h3 id='p-lang-label'>Languages</h3>

			<div class="body">
									<ul>
						<li class="interlanguage-link interwiki-ar"><a href="//ar.wikipedia.org/wiki/%D9%85%D8%AA%D9%84%D8%A7%D8%B2%D9%85%D8%A9_%D8%A7%D9%86%D8%AD%D9%84%D8%A7%D9%84_%D8%A7%D9%84%D8%AF%D9%85_%D8%A7%D9%84%D9%8A%D9%88%D8%B1%D9%8A%D9%85%D9%8A" title="     Arabic" lang="ar" hreflang="ar"></a></li><li class="interlanguage-link interwiki-ca"><a href="//ca.wikipedia.org/wiki/S%C3%ADndrome_hemol%C3%ADticour%C3%A8mica" title="Sndrome hemolticourmica  Catalan" lang="ca" hreflang="ca">Catal</a></li><li class="interlanguage-link interwiki-da"><a href="//da.wikipedia.org/wiki/H%C3%A6molytisk-ur%C3%A6misk_syndrom" title="Hmolytisk-urmisk syndrom  Danish" lang="da" hreflang="da">Dansk</a></li><li class="interlanguage-link interwiki-de"><a href="//de.wikipedia.org/wiki/H%C3%A4molytisch-ur%C3%A4misches_Syndrom" title="Hmolytisch-urmisches Syndrom  German" lang="de" hreflang="de">Deutsch</a></li><li class="interlanguage-link interwiki-es"><a href="//es.wikipedia.org/wiki/S%C3%ADndrome_ur%C3%A9mico_hemol%C3%ADtico" title="Sndrome urmico hemoltico  Spanish" lang="es" hreflang="es">Espaol</a></li><li class="interlanguage-link interwiki-fa"><a href="//fa.wikipedia.org/wiki/%D9%86%D8%B4%D8%A7%D9%86%DA%AF%D8%A7%D9%86_%D9%87%D9%85%D9%88%D9%84%DB%8C%D8%AA%DB%8C%DA%A9_%D8%A7%D9%88%D8%B1%D9%85%DB%8C%DA%A9" title="    Persian" lang="fa" hreflang="fa"></a></li><li class="interlanguage-link interwiki-fr"><a href="//fr.wikipedia.org/wiki/Syndrome_h%C3%A9molytique_et_ur%C3%A9mique" title="Syndrome hmolytique et urmique  French" lang="fr" hreflang="fr">Franais</a></li><li class="interlanguage-link interwiki-id"><a href="//id.wikipedia.org/wiki/Sindrom_uremik-hemolitik" title="Sindrom uremik-hemolitik  Indonesian" lang="id" hreflang="id">Bahasa Indonesia</a></li><li class="interlanguage-link interwiki-it badge-Q17437798 badge-goodarticle" title="good article"><a href="//it.wikipedia.org/wiki/Sindrome_emolitico-uremica" title="Sindrome emolitico-uremica  Italian" lang="it" hreflang="it">Italiano</a></li><li class="interlanguage-link interwiki-lb"><a href="//lb.wikipedia.org/wiki/H%C3%A4molytescht-ur%C3%A4mescht_Syndrom" title="Hmolytescht-urmescht Syndrom  Luxembourgish" lang="lb" hreflang="lb">Ltzebuergesch</a></li><li class="interlanguage-link interwiki-nl"><a href="//nl.wikipedia.org/wiki/Hemolytisch-uremisch_syndroom" title="Hemolytisch-uremisch syndroom  Dutch" lang="nl" hreflang="nl">Nederlands</a></li><li class="interlanguage-link interwiki-ja"><a href="//ja.wikipedia.org/wiki/%E6%BA%B6%E8%A1%80%E6%80%A7%E5%B0%BF%E6%AF%92%E7%97%87%E7%97%87%E5%80%99%E7%BE%A4" title="  Japanese" lang="ja" hreflang="ja"></a></li><li class="interlanguage-link interwiki-no"><a href="//no.wikipedia.org/wiki/Hemolytisk-uremisk_syndrom" title="Hemolytisk-uremisk syndrom  Norwegian" lang="no" hreflang="no">Norsk bokml</a></li><li class="interlanguage-link interwiki-nn"><a href="//nn.wikipedia.org/wiki/Hemolytisk_uremisk_syndrom" title="Hemolytisk uremisk syndrom  Norwegian Nynorsk" lang="nn" hreflang="nn">Norsk nynorsk</a></li><li class="interlanguage-link interwiki-nds"><a href="//nds.wikipedia.org/wiki/H%C3%A4molyytsch-ur%C3%A4%C3%A4msch_Syndrom" title="Hmolyytsch-urmsch Syndrom  Low German" lang="nds" hreflang="nds">Plattdtsch</a></li><li class="interlanguage-link interwiki-pl"><a href="//pl.wikipedia.org/wiki/Zesp%C3%B3%C5%82_hemolityczno-mocznicowy" title="Zesp hemolityczno-mocznicowy  Polish" lang="pl" hreflang="pl">Polski</a></li><li class="interlanguage-link interwiki-pt"><a href="//pt.wikipedia.org/wiki/S%C3%ADndrome_hemol%C3%ADtico-ur%C3%AAmica" title="Sndrome hemoltico-urmica  Portuguese" lang="pt" hreflang="pt">Portugus</a></li><li class="interlanguage-link interwiki-ro"><a href="//ro.wikipedia.org/wiki/Sindromul_hemolitic-uremic" title="Sindromul hemolitic-uremic  Romanian" lang="ro" hreflang="ro">Romn</a></li><li class="interlanguage-link interwiki-sk"><a href="//sk.wikipedia.org/wiki/Hemolyticko-uremick%C3%BD_syndr%C3%B3m" title="Hemolyticko-uremick syndrm  Slovak" lang="sk" hreflang="sk">Slovenina</a></li><li class="interlanguage-link interwiki-sr"><a href="//sr.wikipedia.org/wiki/%D0%A5%D0%B5%D0%BC%D0%BE%D0%BB%D0%B8%D1%82%D0%B8%D1%87%D0%BA%D0%B8_%D1%83%D1%80%D0%B5%D0%BC%D0%B8%D1%98%D1%81%D0%BA%D0%B8_%D1%81%D0%B8%D0%BD%D0%B4%D1%80%D0%BE%D0%BC" title="    Serbian" lang="sr" hreflang="sr"> / srpski</a></li><li class="interlanguage-link interwiki-sv"><a href="//sv.wikipedia.org/wiki/Hemolytiskt_uremiskt_syndrom" title="Hemolytiskt uremiskt syndrom  Swedish" lang="sv" hreflang="sv">Svenska</a></li><li class="interlanguage-link interwiki-ta"><a href="//ta.wikipedia.org/wiki/%E0%AE%9A%E0%AE%BF%E0%AE%B5%E0%AE%AA%E0%AF%8D%E0%AE%AA%E0%AE%A3%E0%AF%81%E0%AE%9A%E0%AF%8D%E0%AE%9A%E0%AE%BF%E0%AE%A4%E0%AF%88%E0%AE%B5%E0%AF%81_-_%E0%AE%9A%E0%AE%BF%E0%AE%B1%E0%AF%81%E0%AE%A8%E0%AF%80%E0%AE%B0%E0%AE%95%E0%AE%9A%E0%AF%8D%E0%AE%9A%E0%AF%86%E0%AE%AF%E0%AE%B2%E0%AE%BF%E0%AE%B4%E0%AE%AA%E0%AF%8D%E0%AE%AA%E0%AF%81%E0%AE%95%E0%AF%8D_%E0%AE%95%E0%AF%82%E0%AE%9F%E0%AF%8D%E0%AE%9F%E0%AE%B1%E0%AE%BF%E0%AE%95%E0%AF%81%E0%AE%B1%E0%AE%BF" title=" -    Tamil" lang="ta" hreflang="ta"></a></li><li class="interlanguage-link interwiki-th"><a href="//th.wikipedia.org/wiki/%E0%B8%81%E0%B8%A5%E0%B8%B8%E0%B9%88%E0%B8%A1%E0%B8%AD%E0%B8%B2%E0%B8%81%E0%B8%B2%E0%B8%A3%E0%B9%80%E0%B8%A1%E0%B9%87%E0%B8%94%E0%B9%80%E0%B8%A5%E0%B8%B7%E0%B8%AD%E0%B8%94%E0%B9%81%E0%B8%94%E0%B8%87%E0%B9%81%E0%B8%95%E0%B8%81-%E0%B8%A2%E0%B8%B9%E0%B8%A3%E0%B8%B5%E0%B9%80%E0%B8%A1%E0%B8%B5%E0%B8%A2" title="-  Thai" lang="th" hreflang="th"></a></li><li class="interlanguage-link interwiki-tr"><a href="//tr.wikipedia.org/wiki/Hemolitik_%C3%BCremik_sendrom" title="Hemolitik remik sendrom  Turkish" lang="tr" hreflang="tr">Trke</a></li><li class="interlanguage-link interwiki-zh"><a href="//zh.wikipedia.org/wiki/%E6%BA%B6%E8%A1%80%E6%80%A7%E5%B0%BF%E6%AF%92%E7%BB%BC%E5%90%88%E5%BE%81" title="  Chinese" lang="zh" hreflang="zh"></a></li><li class="uls-p-lang-dummy"><a href="#"></a></li>					</ul>
				<div class='after-portlet after-portlet-lang'><span class="wb-langlinks-edit wb-langlinks-link"><a href="//www.wikidata.org/wiki/Q162266#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>			</div>
		</div>
				</div>
		</div>
		<div id="footer" role="contentinfo">
							<ul id="footer-info">
											<li id="footer-info-lastmod"> This page was last modified on 22 March 2016, at 08:10.</li>
											<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
									</ul>
							<ul id="footer-places">
											<li id="footer-places-privacy"><a href="//wikimediafoundation.org/wiki/Privacy_policy" title="wmf:Privacy policy">Privacy policy</a></li>
											<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
											<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
											<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
											<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
											<li id="footer-places-cookiestatement"><a href="//wikimediafoundation.org/wiki/Cookie_statement">Cookie statement</a></li>
											<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Hemolytic-uremic_syndrome&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
									</ul>
										<ul id="footer-icons" class="noprint">
											<li id="footer-copyrightico">
							<a href="https://wikimediafoundation.org/"><img src="/static/images/wikimedia-button.png" srcset="/static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation"/></a>						</li>
											<li id="footer-poweredbyico">
							<a href="//www.mediawiki.org/"><img src="/w/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="/w/resources/assets/poweredby_mediawiki_132x47.png 1.5x, /w/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31"/></a>						</li>
									</ul>
						<div style="clear:both"></div>
		</div>
		<script>(window.RLQ=window.RLQ||[]).push(function(){mw.loader.state({"ext.globalCssJs.site":"ready","ext.globalCssJs.user":"ready","user":"ready","user.groups":"ready"});mw.loader.load(["ext.cite.a11y","mediawiki.toc","mediawiki.action.view.postEdit","site","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.searchSuggest","ext.eventLogging.subscriber","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.DRN-wizard","ext.gadget.charinsert","ext.gadget.refToolbar","ext.gadget.switcher","ext.gadget.featured-articles-links","mmv.bootstrap.autostart","ext.visualEditor.targetLoader","ext.wikimediaEvents","ext.navigationTiming","schema.UniversalLanguageSelector","ext.uls.eventlogger","ext.uls.interlanguage"]);});</script><script>(window.RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgBackendResponseTime":777,"wgHostname":"mw1252"});});</script>
	</body>
</html>
